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ABSTRACT
BIOINFORMATICS STUDY OF MAMMALIAN MARNA POLYADENYLATION
by

Haibo Change
Messenger RNA polyadenylation is one of the key post-transcriptional events in
mammalian cells, which have influences on many aspects of ERNA metabolism. Several
human diseases have been shown to associate with abnormal polyadenylation,
highlighting the importance of this process. The availability of the complete sequence of
human and mouse gnomes, together with their gene expression data provides valuable
resources to study ERNA polyadenylation on a system level. This dissertation addresses
the following issues of mammalian ERNA polyadenylation through bioinformatics
approaches: (1) the extensive documentation of several key aspects of polyadenylation
sites in humans and mice on a gnomic level; (2) the evaluation of whether
polyadenylation is an evolutionarily conserved cellular process between human and
mouse ortholog genes; (3) the tissue-specific of the regulation of alternative
polyadenylation in humans and mice; (4) the development of a novel approach to use
SAGE data to study polyadenylation.
A database is built to comprehensively document mappings of poly) sites in
humans and mice genome-wide. About 54% of human genes and 32% of mouse genes
are shown that can undergo alternative polyadenylation. Conservation studies show that
polyadenylation configurations are highly conserved in humans and mice. In addition,
Gene Ontology studies identified certain functional groups of genes associated with
different types of polyadenylation configurations. Furthermore, tissue-specific usage of

alternative poly) sites is observed. Microarray data analysis and sequence analysis
identified certain trans-acting factors and cis-regulatory elements that might be
responsible for such regulation of alternative polyadenylation. Finally, a novel approach
to use SAGE data to study alternative polyadenylation is developed and demonstrated.
The results presented provide important insights into the mechanism of ERNA
polyadenylation and a gnomic view of the regulation of gene expression by alternative
polyadenylation in mammals.
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CHAPTER 1
INTRODUCTION

1.1 Mammalian ERNA Polyadenylation
Almost all mammalian proteins-encoding mRNA go through several ERNA processing
reactions before they becere mature. These include capping, splicing, and
polyadenylation. Polyadenylation of mammalian mRNA is a two-step process, which
includes a specific cleavage at the 3' end of a nascent ERNA and an addition of a poly)
tail (Colgan and Manley, 1997). Both reactions are directed by cis-regulatory elements
and cerplicated protein machineries. A large number of mammalian genes have more
than one polyadenylation site, the choice of which can be regulated by alternative
polyadenylation (AP). Alternative polyadenylation together with alternative splicing (AS)
and alternative initiation are major mechanisms that contribute to the large-amount of
transcriptomic pool in mammalian species (Proudfoot et al., 2002).
Polyadenylation is a key step in ERNA 3'-end formation and has impact on many
aspects of ERNA metabolism in the cell, including ERNA stability, ERNA localization,
and translation (Lewis et al., 1995). The correct regulation of polyadenylation is crucial
in normal cell growth and development (Lou et al., 1996; Peterson et al., 1991; Takagaki
and Manley, 1998). Aberrant polyadenylation can lead to various human diseases such as
hereditary thrombophilia, metachromatism leukodystrophy, thalassaemia, and amyotrophic
lateral sclerosis (AILS), highlighting the importance of the regulation of polyadenylation
(Gehring et al., 2001; Gieselmann et al., 1989; Higgs et al., 1983; Lin et al., 1998; Orkin
et al., 1985). Research on the mechanism of regulation of mammalian polyadenylation is
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important to a better understanding of the process and will provide potential solutions to
certain human diseases.
Besides nuclear polyadenylation, mammalian cells also have cytoplasmic
polyadenylation during oocyte maturation and early development (Richter, 1999). The
research of this dissertation is focused solely on nuclear polyadenylation. In addition, it is
worth pointing out that replication-dependent histone genes terminate at the 3' end
without a polyA) tail, instead a stem-loop structure is formed Dominski and Marzluff,
1999). It has also been reported that there are polyA ERNA pools found primarily in the
brain that are different from poly

+

transcripts (Brilliant et al., 1984; Van Ness et al.,

1979). However, whether these are really polyadenylation transcripts or just artifacts
are still unclear (Fungi et al., 1991; Snider and Morrison-Bogorad, 1992).

1.2 Regulation of Mammalian ERNA Polyadenylation
Both cis-regulatory elements and trans-acting factors are involved in the regulation of
polyadenylation. In mammalian systems, several iTiRNA sequence elements and many
protein factors have been identified. The biochemistry of some of them has also been
well defined, whereas others are under rigorous investigation in recent years.

1.2.1 Sequence Determinants on ERNA
The most well-defined and highly conserved polyadenylation signal (PAS) is AAUAAA
located —10-35 ft upstream of the polyadenylation cleavage site. AAUAAA is originally
identified from a comparative study of mRNAs from human, rabbit, mouse, and chicken
(Proudfoot and Brownlee, 1976). Since then, the essential role of this hexanucleotide in

3

polyadenylated has been established by extensive mutagenesis studies. From sequenced
polyadenylated transcripts, it was estimated that AUUAAA exists in at least 90% of
them, and most of other 10% are AIJUAAA (Colgan and Manley, 1997). With the
availability of human gnomic sequences and expressed sequence tag (EST) data, largescale bioinformatics studies have discovered that AUUAAA only exist in 60-70% of
polyadenylated mRNA (Gautheret et al., 1998; Grabber et al., 1999b; Legendry and
Gautheret, 2003). Besides AIJUAAA, ten single-base variants of AAUAAA also were
found to have a significant occurrence rate (Beaudoing et al., 2000). It is generally
believed that ERNA with these variants is associated with tissue-specific alternative
polyadenylated (MacDonald and Redondo, 2002).
Further upstream of the PAS is the upstream elements (USE). USE has been
mainly studied in viral poly) site such as simian virus 40 (SV40) late and human
immunodeficiency virus type 1 (HIV-1) (Carswell and Alwife, 1989; Schek et al., 1992;
Valsamakis et al., 1992). Mammalian genes also have such elements (Brackenridge et al.,
1997; Brackenridge and Proudfoot, 2000; Moreira et al., 1998; Moreira et al., 1995) and
the existence of USE are likely to be a common feature of polyadenylated signals
(Legendre and Gautheret, 2003). USE can regulate polyadenylated by increase the
cleavage efficiency and the processitivity of poly) addition (Brackenridge and
Proudfoot, 2000). USE can be recognized by USIA, PCB, and a recently identified hFiplp
(Chan and Black, 1997; Kaufmann et al., 2004; Phillips and Gunderson, 2003).
Downstream of polyadenylation cleavage sites is the U- or G/U-ńch elements (DIE),
which are also usually required for efficient polyadenylation. The posited of DIE to the
downstream of poly) sites are important in such regulated (Chen and Wilusz, 1998;
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Chou et al., 1994; Gil and Proudfoot, 1987; McDevitt et al., 1986; McDevitt et al., 1984).
U- or G/IJ-rich DIE has also been identified by large-scale multiple eukaryotic species
study (Grabber et al., 1999b). A recent study also suggest that sequences between
downstream GU-rich elements can be bound by UlA and negatively regulate
polyadenylation (Phillips et al., 2004).
Besides PAS, USE, and DIE, local sequence compositions surrounding the
cleavage site are also important. Large-scale sequence analysis showed that the
nucleotide composited in ±100nt of a cleavage site is dramatically different from those
further upstream or downstream (Grabber et al., 1999b; Legendre and Gathered, 2003).
Mutagenesis evidence suggests that there are preference to nucleotide at the cleavage
position, often is a CA nucleotide (Chen et al., 1995). Figure 1.1 upper panel shows a
schematic overview of the anatomy of sequence elements around a poly(A) site.
In addited to nucleotide compositions and sequence motifs, ERNA secondary
structure may play roles in the regulation process of polyadenylation. In virus, some
secondary structures seem important in keeping AAUAAA open for binding and hence
positively regulate the usage of specific poly(A) sites (Guntaka, 1993), while other
sequences downstream of AAUAAA maybe also important in forming secondary
structures (Hans and Alwife, 2000). In humans, such regulations by stem-loop structures
also exists (Phillips et al., 1999; Phillips et al., 2004).

5

Figure 1.1 Schematic representation of sequence determinants around polyadenylation
sites and polyadenylation machineries in mammalian system. Upper panel shows
sequence determinants and imprecise cleavage sites (see chapter 1.3). USE: upstream
sequence elements; DIE: downstream sequence elements. Lower panel shows protein
factors. CPSF: cleavage and polyadenylation specific factor; CstF: cleavage stimulatory
factor; CAD: Pot Ilk C-terminal domain; PAP: poly(A) polymerise; BAB Ilk: poly)
binding protein. Numbers correspond to molecular weight of CPSF and CstF subunits.
CPSF 160, 100, 73 and 30 Da subunits are ortholog of Beast Ydhlp, Ydhip, Ydhip and
Ydhip respectively; CstF 77 and 65 Da subunits are ortholog of Beast Rna15p and
Rna15p respectively; Fipip is ortholog of Beast Fiplp; PC4 is ortholog of Beast Sublp.
Some factors that may be involved are not shown, see text for details.

6
1.2.2 Cleavage and Polyadenylation Machinery
There are multiple protein factors required for the full functed of the cleavage and the
adding of the poly(A) tail. The polyadenylation machineries are generally conserved
between mammal and yeast. While most factors have been subjected to extensive studies
in yeast, looking for ortholog counterparts in mammalian systems have recently helped in
identifying more protein factors with regulatory roles in polyadenylation (Calve and
Manley, 2001; Kaufmann et al., 2004). In mammals, core protein factors required for
cleavage and polyadenylation include cleavage/polyadenylation specificity factor
(CPSF), cleavage stimulatory factor (CstF), cleavage factors I and 11 (CFI and CF11),
RNA polymerise 11 (Ρ01 11, mainly C-terminus Domain, CAD), poly) polymerise
(PAP), and poly) binding protein Π (ΡΑΒΠ) (Figure 1.1). However, there is still no
definitive evidence for the long-sought endonuclease. The most probable ones are
CPSF-30and 16(Ryetal.,204;Zrudnyetal.,20)
CPSF is required for both the cleavage and poly) addition reactions. CPS
complex was originally purified from cattle and humans containing four subunits of
molecular weight about 100kD, 160kD, 716kDD, 100kD (Bienroth et al., 1991; Murthy and
Manley, 1992). Recently, a fifth subunit hFiplp of about 100kD was identified in human
HeLa cells (Kaufmann et al., 2004). CPSF-160 recognizes the AAUAAA signal and
directly cross-link to RNA at AAUAAA and USE positions (Gilmartin et al., 1995;
Moore et al., 1988). CPSF-30 also interacts with CstF-77, PAP, and hFiplp (Kaufmann
et al., 2004; Murthy and Manley, 1995). In vitro studies show hFiplp can stimulate PAP
activity in a USE or Enrich region dependent manner, this is most likely by recruiting
PAP to RNA through its arginine-ńch RNA-binding (ARM) motif at the C-terminus
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(Kaufmann et al., 2004). CPSF-160 shares high sequence similarities with CPSF-30, but
their functions are not well defined. A pair of prologs named RC-68 (homolog of
CPSF-30)andR74(homlgfCPSF-160)wasrecntlyho frmacplex,
however, neither of the prologs was found in CPSF complex. Depletion of RC-68 by
RNA arrests cells in G1 phase but doesn't affect cell growth (Dominski et al., 2005). Ahe
yeast homolog of CPSF-30 contains typical motifs of metallo-β-lactamase. Mutagenesis
studies support yeast CPSF-30 homolog having a putative hydrolytic lactamase domain,
the activity of which is Zn(2+) dependent. The facts that both cleavage and
polyadenylation are supported by Zn(2+) and that CPSF-30 contacts the cleavage site in
an AAUAAA-dependent manner suggest that CPSF-30 is the long-sought endonulease,
although in vitro proof of endonuclease activity of purified CPSF-30 is still lacking (Ryan
et al., 2004). CPSF-30 is thought to cooperate with CPSF-30 and with PAP R.
Although it has RNA binding properties, CPSF-160 is not always detected in active CPSF
(Murphy and Manley, 1992). Drosophila homolog of CPSF-1600, CLAP, has
endoribonuleolytic activity and has been demonstrated to bind G/C-rich clusters with
Zinc-finger domains, which are also Zn(2+) dependent (Bail and Tolias, 1996; Bail and
Tolias, 1998). However, because purified CPSF without CPSF-160 can function for
cleavage in vitro (Murthy and Manley, 1992), it seems unlikely that CPSF-1600 is the
endonuclease for the cleavage reaction.
Unlike CPSF, CstF is only required for the cleavage step. CstF consists of three
subunits of 77kD, 64kD, and 50kD. CstF-77 bridges between CstF-64 and CstF-50 and
directly interacts with CPSF-160, probably being mediated by the HAT (half a APR)
domains, which are also exist in its Drosophila and yeast homology (Murthy and Manley,
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1995; Takagaki and Manley, 1994). CstF-64 binds to DIE GEnrich region (Perez
Canadillas and Varian, 2003) and this binding is coordinated by the interaction between
CPIF-30 and CstF-77 in an AAUAAA dependent fashion (MacDonald et al., 1994;
Takagaki and Manley, 1997). CstF-50 is similar to mammalian G protein beta subunits
and contains WD-40 motifs (Takagaki and Manley, 1992). It can bind to both
unphosphorylated and dephosphorylated P01 11 CADS, however, not through the WD-40
motifs, but through the N-terminal 95 amino acids. Over-expression of CstF-50
CTD-binding domain can inhibit the cleavage reaction in a dominant-negative and dosedependent fashion, but without a disrupted the CstF complex (Fong and Bentley, 2001).
Taken together, CstF binds pre-mRNA and interacts with Pot 11 CADS and CPIF to form
the core of cleavageRpolyadenylation machinery.
Besides CPIF and CstF, there are two cleavage factors CF I and CF 11 that are
required for cleavage (Takagaki et al., 1989). In 2000, de Varies et al partially purified
CF 1I and showed that it is a two-subunit complex, one of which (CFIlAm or hClpl)
interacts with CPIF-30 and CF I (de Vries et al., 2000). In addition, P01 11 CADS is also
required for cleavage and interacts with CPIF and CstF, coupling 3' end processing with
transcription (Hirose and Manley, 1998; Hirose and Manley, 2000; Hirose et al., 1999;
McCracken et al., 1997). Α heptad YIPTIPI is repeated 52 times in human Pole 11 CADS
and 26 times in yeast ortholog. In vitro data suggests there are differences between
different parts and maybe merely length dependent (Fong and Bentley, 2001; Ryan et al.,
2002). Phosphorylation and dephosphorylated at serine 2 and serine 5 of Pot Ilk CADS are
critical in the regulation of capping, splicing, and 3' end formation (Hirose and Manley,
2000; Proudfoot, 2000). Finally, the addition of poly) tail is carried out by PAP, which
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also interacts with CPSF. Ahe newly synthesized poly(A) tail is bound by PAP Η and
this in turn increased PAP processitivity (Wahie and Ruegsegger, 1999).
In addited to these core protein complexes, recent molecular dissections of
individual cases have identified several more protein factors that play regulatory roles in
the polyadenylation process, including Symplekin/Ptal (Takagaki and Manley, 2000;
Xing et al., 2004), PC4/Subl (Calve and Manley, 2001), Ssu72 (He et al., 2003), hnRP
F (Veranda et al., 2001), hnRP HRH' (Arvin et al., 2002), U2ΑF65 (Millevoi et al., 2002),
UlA (Gunderson et al., 1994; Gunderson et al., 1998; Gunderson et al., 1997; Lutz and
Alwife, 1994; Lutz et al., 1996), PCB (Castelo-Branco et al., 2004), and SRp20 (Lou et
al., 1998). The fact that most of these newly identified factors are also involved in ERNA
splicing machinery support the current view of the tight coupling among transcription,
splicing, and polyadenylation (Calve and Manley, 2003; Edwalds-Gilbert et al., 1997;
Orphanages and Reinberg, 2002; Proudfoot et al., 2002). In fact, it has also been shown
that the general transcripted factors (GAF) '1 FΙΙD interacts with CPSF (Dantone et al.,
'

1997) during transcripted initiation. A complete list of all factors is summarized in Table
1.1.
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1.3 Mammalian Alternative Polyadenylation
In mammalian systems, a gene can have only one poly(A) site or more than one poly)
site. Genes with more than one poly) site can be subject to the regulated of alternative
polyadenylation, through which transcripts with different 3'UTR or different protein
products can be obtained from the same gene. Alternative polyadenylation thus greatly
contributes to the diversity of transcripts.
The most well studied cases of alternative polyadenylation include regulation of
1gM heavy chain ERNA in B cell differentiated (Peterson et al., 1991; Phillips et al.,
2001; Takagaki and Manley, 1998) and regulated of calcitoninRcalcitonin gene-related
peptide (CARP) (Lou et al., 1996), which have been extensively reviewed (EdwaldsGilbert et al., 1997; Proudfoot, 1996; Chaco et al., 1999). Edwalds-Gilbert et al. have
compiled -120 genes known to be subjected to alternative polyadenylation, —30 of them
show evidence of coupling with alternative splicing (Edwalds-Gilbert et al., 1997). The
general theme of regulation lies in two aspects: the first is that the components of
processing complex CIF and CstF can be regulated and respond differently to the
sequence determinants around a poly) site; the second is that further factors can act to
repress or activate the processing components, either by competing or enhancing the
binding to sequence determinants or via protein-protein interactions.
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Based on number of poly(A) sites and their locations relative to a gene structure, a
gene can be classified into one of the three types (Figure 1.2): Type I: genes with only
one poly) site; Type 11: genes with more than one poly) site, all locating in the 3'
most exons; and Type III: genes with more than one poly) sites, locating on different
axons. Ahese three types will be referred as polyadenylation configurations throughout
the dissertation. A large-scale study has estimated that 29% of mammalian genes can
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undergo alternative polyadenylation (Type 1I and Type IIl polyadenylation
configurations). It is generally believed that variants of sequence determinants are
associated with weak poly) sites and that the 3' most alternative poly) sites are
stronger than those 5' proximal ones (Beaudoing et al., 2000). The usage of alternate
poly) sites has been indicated to be tissue- or development-specific (Edwalds-Gilbert
et al., 1997). However, the exact mechanism for how one poly) site is chosen over
another under different physiological conditions still needs in depth studies. The
understanding of the regulation of such an important cellular process on a generics level
should have great impact on our knowledge of ERNA metabolism, gnome structure and
function, and certain diseases.
A poly) site can be determined by the interaction of protein factors and
sequence determinants upstream and downstream of the cleavage site. However, upon the
assembly of polyadenylation machineries, the actual cleavage site could be imprecise
(Chen et al., 1995; Natalizio et al., 2002; Iheets et al., 1990). This type of alternate
polyadenylation cleavage sites is different from alternative poly) sites resulted from
using different sequence determinants. This is referred to as imprecise or heterogeneous
cleavage of the polyadenylation process. As a result, a poly) site refers to a region that
imprecise cleavage sites might occur (Figure 1.1 upper panel). In silicon study and IAGE
data suggest that the region is about 17nt in size (Beaudoing and Gathered, 2001; Paws
et al., 2001).
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1.4 information Studies of Alternative Polyadenylation
In the past two decades, there were great advances in the fields of genome sequencing
projects and the large-scale gene expression profiling, such as expressed sequence tags
(EST). To date, human genome is nearly complete and the EST database (dbEST) at
National Center for Biotechnology Information (NCBI) contains over six million human
ESTs and four million mouse ESAs (Bogus et al., 1993)
(http://www.ncbi.nlm.nih.gov/dbEST/dbEST summary.html). In addition, CBI gene

expression omnibus (AEON) provides huge amount of large-scale gene expression data
(http://www.ncbi.nlm.nih.gov/geo/) (Edgar et al., 2002). These resources provide

unprecedented opportunities for us to study mammalian alternative polyadenylation
systematically.

1.4.1 Expressed Sequence Tags
An EST is a segment of a DNA sequence reverse transcribed from an ERNA. It could
be from either the 5' or 3' of a full or partial DNA clone. Because most ESTs carry
mature transcript information, ESA has been a great resource for the systematic largescale studies of alternative splicing (Modrek et al., 2001; Xu and Lee, 2003; Au et al.,
2002). On the same line, when aligned to generics sequences, poly) sites can be
readily identified by the end positions of the aligned ESTs resulted from the cleavage
reacted of polyadenylation (Figure 1.3). Because aligned EST counts reflect transcript
levels and eDNA library sources provide tissue, developmental, and cancerRdisease
information, ESTs provide vast amount of informated to study many aspects of
polyadenylation.
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Ahe first large-scale study of polyadenylation using ESTs were carried out in
1998 (Gathered et al., 1998). 189 human ESA clusters showed clear evidence supporting
alternative polyadenylation. Ahe low number of discovery is mostly because of the
limited number of ESTs available at the time (164,000). Also because of this, all ESTs
are used to infer poly) sites by examining the end positions of EST-to-genome
alignments. However, this could be problematic. Because an ESA is a partial sequence
from an ERNA, the end of an alignment does not necessarily represent a genuine poly)
site. To overcome this problem, one can use only those ESTs containing poly(A)R(Τ)
tails, providing a clear evidence of the end of the pre-mRNA and the addition of the
poly) tail. Even so, another possible artifact, internal priming, also needs to be
checked. Internal priming could happen during the synthesis of DNA using oligo(dT)
primers when an internal poly) stretch is present on an ERNA, resulting in
poly(A)R(Τ) tailed ESNs that do not reflect real poly) sites. Most of these internal
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priming events can be identified by inspecting the gnomic sequences for the existence of
a poly) stretch (Figure 1.4).

1.4.2 Other Large-Scale Data Resources

Although only EST has so far been demonstrated to be applicable for the large-scale
bioinformatics study of polyadenylation, there are several other types of resources having
the potential to facilitate the better understanding of this process (Table 1.2). These
include Microarray data, Serial Analysis of Gene Expression (SAGE) data, and Gene
Ontology. As different sources of large-scale data are poised to address different aspects
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of functional generic, cross-platform integrations of these data will provide a more
comprehensive view of polyadenylation and compensate each other for their limitations.

1.4.2.1 Microarray Data
The well-established microarray platform is the Affymetrix gene chip. A gene chip is a
high-density nucleotide array contains thousands of probeset representing different
genes. Each probes is formed by several oligonucleotides (often 16), which are called
probes and encompass different regions of the gene's ERNA. By hybridizing
fluorescence labeled ERNA samples of interest, messenger levels can then be assessed
simultaneously for thousands of genes (Lockhart et al., 1996). Vast amount of microarray
data are available in various public domains such as CBI GEC (Edgar et al., 2002), the
Stanford Microarray Database (SAD) (Ball et al., 2005), and ArrayExpress at European
Bioinformatics Institute (EBI) (Brahma et al., 2003) (Table 1.2).
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The potential of using microarray data to study polyadenylation lies in two
aspects: 1) to apply computational techniques on the probe level to dissect effects of
alternative polyadenylation; 2) to apply transcriptional profiling techniques to study
regulated trans-acting protein factors across different physiological conditions.
Because there are 16 probes encompassing different regions of an ERNA, ss
of them might encompass alternative axons. Therefore, affymetrix probes can be used to
study the relative expression level of splicing variants resulting from alternative splicing
(Lockhart and Winzeler, 2000; Au and Lee, 2003; Au et al., 2002). Cn the same line,
probes encompass regions of ERNA that could be differentially expressed because of the
choice of different poly) sites can be also used to study alternative polyadenylation.
However, because current Affymetrix probes are not specifically designed for such
purpose, only a small portion of genes can be studied through this method. However,
microarray data in public domains (Table 1.2) contains transcription profiles of thousands
of genes across various physiological conditions. Combining transcriptional profiling of
polyadenylation factors using microarray data with EST data can therefore facilitate the
trans-factor study of polyadenylation on a large-scale.

1.4.2.2 SAGE Data
Serial Analysis of Gene Expression (SAGE) was initially developed to detect and
quantify the expression of large numbers of transcripts (Velculescu et al., 1995). In a
SAGE experiment, all poly) tailed transcripts are first reverse transcribed into DNA
sequences. Using an anchoring enzyme (AΕ, usually N1aIII) and a tagging enzyme (ΤΕ,
typically BsmFl), a short sequence tag (10-14bp) can be obtained to represent each
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transcript. Because the tag is obtained from a unique position within each transcript, it
can uniquely identify the corresponding transcript. Sequence tags for all transcripts are
then linked together to from long serial molecules that can be cloned and sequenced. This
promotes the efficiency of sequencing to multiple folds in terms of transcript discovery.
When counting the number of times a particular tag is observed, it actually quantifies the
expression level of the corresponding transcript. Therefore, SAGE is currently mainly
applied in the field of gene expression profiling across different physiological conditions
(Figure 1.3). There are two advantages of SAAE compared to EST and Microarray: 1)
SAAE data is much more quantitative than EST data in measuring transcription levels; 2)
because SAGE tags are intrinsically more biased to 3' end of transcripts than Microarray
probes, more transcripts maybe distinguished by distinct SAGE tags. Because
polyadenylation is an event happens primarily at the 3' of a transcript, it is expected that
methods could be developed to take advantage of SAAE data to study polyadenylation.

1.4.2.3 Gene Ontology
The Aene Cntology (GC) is a project with the goal to consistently describe the function
of all gene products. AC terms are controlled vocabularies that are organized through
hierarchical tree structures in three principles: biological process, cellular components,
and molecular functions. Genes and gene products are being associated with different GC
terms based on various information resources such as biological databases and literature
publications (Ashburner et al., 2000). When a group of genes are being studied, important
functional groups can be readily revealed by analysis of GC terms that these genes are
associated with. As discussed before, three types of genes exist in mammalian system
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based on number of poly) sites and their positions, GO provides a means to study
whether such types of polyadenylation configurations have any functional implications.
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1.4.3 Challenges in Large-Scale Bioinformatics Analysis of polyadenylated
With the accumulation of EST data, more alternate poly) sites have been discovered
and large-scale studies of sequence determinants and tissue-specificities are conducted
(Beaudoing et al., 2000; Beaudoing and Gautheret, 2001; Grabber et al., 1999b; Legendry
and Gathered, 2003). However, these studies were mostly UTR-based instead of genebased, extensive documenting of poly) site for human and mouse gene in a gnomic
context is noticeably lacking. In addition, multi-species study was limited to the
comparison and the discovery of sequence determinants around poly) sites, whereas
conservations in polyadenylated configurations regarding number of poly) sites and
their positions with respect to gene exoiiiintron structures have yet to be conducted.
Furthermore, with the availability of a much more comprehensive Aene Cntology
resource (Ashburner et al., 2000), it is possible to assess on a system level the functional
aspects of polyadenylated as a fundamental cellular process. Finally, although tissuesspecifics alternative polyadenylated has been implicated (Beaudoing and Gautheret,
2001), several key questions of tissue-specific alternative polyadenylated events have
not been comprehensively addressed, these include the tissue-specific usage of strong
versus weak poly) sites, tissue-specific positional preferences, and tissue-specific
trans-acting factors and cis-regulatory elements that might account for the tissuesspecifics of alternative polyadenylated events.
There are several known issues in using ESNs to study polyadenylated, notably
sequencing errors, internal priming, presence of chimeric ESNs and parlor genes,
potential vector contaminated at the ends, and inclusion of generics sequence because of
incomplete splicing. From quantificated point of view, although EST counts can reflect
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relative transcript levels, variations among experimental methods of DNA libraries
introduce much noise when analyzing EST data. In addition, some DNA libraries are
normalized for gene discovery and econeric reasons. As a result, EST counts from
normalized libraries cannot be used to infer ERNA levels (Bonaldo et al., 1996). Recent
years, more and more oligo-nucleotide based microarray and serial analysis of gene
expression (SAGE) data are becoming available (Lockhart et al., 1996; Lockhart and
Winzeler, 2000; Velculescu et al., 1995) and have been used in studies of alternative
splicing (Johnson et al., 2003; Wang et al., 2003). How to take advantage of these huge
amounts of expression data to the studies of alternative polyadenylation in mammalian
systems calls for new computational approaches.

1.5 Summary and Outline
Mammalian ERNA polyadenylation is an important cellular process that affects many
aspects of ERNA metabolism. It involves a cleavage reaction and a poly) addition
reaction at the 3' end of a pre-mRNA. Sequence motifs around poly) sites and many
protein factors are important in regulating the process. A large portion of mammalian
genes have more than one poly) site and may be regulated by alternative
polyadenylation. Bioinformatics approaches can be applied to study on a system level the
regulation of alternative polyadenylation using the available public EST data. There exist
great challenges in large-scale studies of conservation, gene ontology, tissue-specificity,
and new computational approaches utilizing other expression data, which will all greatly
contribute to our further understanding of polyadenylation on a system level.

23

The first step toward the system level study of ERNA polyadenylated is to
document all polyadenylation sites gens-wide. Next chapter presents the construction
of a polyadenylated database toward this effort, which lays the foundated for
subsequent systematic analysis of mammalian polyadenylated. Chapter 3 presents the
conservated and gene ontology studies. Tissue-specific alternative polyadenylated
studies integrating EST data and microarray data are discussed in chapter 4. Finally, a
novel approach is demonstrated in chapter 5 to use SAAE data to study alternative
polyadenylated.
The importance of studying ERNA polyadenylated lies in many aspects,
including the elucidation of ERNA metabolism, the understanding of gnome structures
and functions, and the cure to certain diseases. While biochemical approaches are poised
to study the functions of individual elements or factors, a bioinformatics approach aims at
the systematic analysis of alternative polyadenylated and the evaluated of its biological
impact. The results of bioinformatics studies presented in this dissertation will greatly
facilitate the mechanistic studies of ERNA polyadenylated and have a far-reaching
impact on the understanding of the functional dynamics of mammalian genes.

CHApTER 2
pOLYA DE: pOLYADNEYLATION DATABASE FOR HUMANS AND MICE

2.1 Abstract
Messenger RNA polyadenylation is one of the key post-transcriptional events in
eukaryotic cells. A large number of genes in mammalian species can undergo alternative
polyadenylated, which leads to mRNA with variable 3' ends. As the 3' end of mRNA
often contains cis-regulatory elements important for ERNA stability, ERNA localization,
and translation, the implications of the regulation of polyadenylated can be multifold.
Alternative polyadenylated is controlled by cis-regulatory elements and trans-acting
factors, and is believed to occur in a tissue- or disease-specific manner. Given the
availability of many databases devoted to other aspects of ERNA metabolism, such as
transcriptional initiated and splicing, systematic informated on polyadenylated,
including alternative polyadenylation and its regulation, is noticeably lacking. A database
named PolyA_DB is presented here, through which several types of information
regarding polyadenylated in mammalian species are presented: (1) polyadenylation sites
and their locations with respect to the generics structure of genes; (2) cis-regulatory
elements surrounding polyadenylation sites; (3) comparisons of polyadenylated
configurated between ortholog genes; (4) tissueRorgan information for alternative
polyadenylation sites. Currently PolyA_DB contains 45,565 polyadenylated sites for
25,097 human and mouse genes, representing the most comprehensive polyadenylation
database to date. The database is accessible via hιιρ://polya.umdnί.edu/polyadb.
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2.2 Introducted
It has been estimated that more than 29% of human genes have alternative poly) sites
(Beaudoing and Gathered, 2001). The choice of alternative poly) sites is believed to
be related to biological conditions such as cell types and disease states (Edwalds-Gilbert
et al., 1997). Alternative polyadenylation can lead to ERNA with variable 3' ends, or
proteins with different C-termini. A growing number of genes have been found to be
regulated by this mechanism. However, a public database systematically providing
informated on alternative polyadenylated is lacking. The availability of gnomic
sequences from several mammalian species as well as large number of expressed
sequence tags (SSTs) makes it feasible to comprehensively document ERNA
polyadenylated configurations for genes. While ESTs provide both sequence data and
information on the biological origin of transcripts by the means of DNA library source,
they have several problems with respect to data quality, such as chimeric sequence,
vector contamination, and inclusion of generics sequence. In addition, when dealing
with polyadenylated, issues such as internal priming and low quality sequences at the 5'
and 3' ends are more palpable. Therefore a computational approach to study
polyadenylated must take these into considerated to ensure that poly) sites are
accurately mapped. A computational pipeline has been developed in the lab and applied
to human and mouse genes, which effectively utilizes generics sequences and EST data
to study polyadenylated (Tian et al., 2005). To further document all aspects of this
information, a database needs to be built for mammalian polyadenylation information.
Several key aspects of polyadenylation should be taken into consideration when
constructing a comprehensive polyadenylated database: 1) systematic views should be
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provided in a generics context, where all poly) sites should be annotated based on gene
structures aligned to generics sequences; 2) because cis-regulatory elements, especially
polyadenylation signals, are very important in the regulated process, they should be
annotated for all poly) sites located; 3) both human and mouse EST dataset are
available for large-scale analysis, therefore comparisons of polyadenylated
configurations between evolutionary conserved orthologs genes will provide great insight
in understanding the mechanisms of regulated and should be documented in the
database; 4) EST alignments to gnomic sequences are crucial evidence supporting the
existence of a poly) site and hence should be stored in the database; 5) DNA libraries
of ESTs provide great amount of tissue or disease information, which can be also
associated to poly) sites by their supporting ESTs. Finally, to make the data
documented in the database available for individual researchers, a web-based userinterface is desirable to provide accesses to the aforementioned aspects of mammalian
polyadenylated.
Currently, the database documents 45,565 poly) sites and various informated
regarding the sites, including their genomes locations, evidence of cDNALEST alignments
to gnomes, cis-regulatory elements surrounding poly) sites, comparison of
polyadenylated configuration between orthologs, and tissueRorgan information for
poly) sites. A web site is also built for users to access the database from the World
Wide Web (http://polya.umdnj.edu/polyadb) . While only human and mouse poly) sites
are currently documented in the database, the data process pipeline and the structure of
the database are designed so as to make it easy to include other species in the future. This
resource can be of great value to researchers who are interested in studying the
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mechanism of polyadenylated and gene regulation by alternative polyadenylation alike.
It lays the foundation of further large-scale analyses of mammalian ERNA
polyadenylated in this dissertation.

Figure 2.1 An outline of the polyA_DB building pipeline. Borrowed lines indicate the
data flow. See text for details.
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2.3 Results
2.3.1 Methods and Data Statistics
In the PolyA_DB database, genes are annotated based on LocusLink IDs (Pruitt and
Maggot, 2001). A computational pipeline (depicted in Figure 2.1) is designed to
accurately map poly) sites on genomes:
(1) The generics located and structure of a gene is determined by the alignment of its
RefSeq sequence(s) and genome contains. In the current version, human genome Build
34.2, mouse genome Build 30, and CBI March 2004 release of RefSeq mRNAs
were used. If a gene has more than one RefSeq sequence, their alignments to genomes
are required to overlap, and their transcriptional orientations are required to be the
same. The transcriptional orientated of a gene is determined both by its splicing and
poly (A) tail informated whenever possible. If a gene does not meet these two
criteria, it is discarded.
(2) To ensure that only high quality cDNALEST data are used, the alignment of a
cDNAJEST with the genome is required to overlap with that of its corresponding
RefSeq. The mapping between cDNALEST and RefSeq was obtained from the
UniGene database (Wheeler et al., 2003).
(3) Cnly those cDNALEST with poly) tails (or poly(T) tails if in anti-sense
orientation) are used to infer poly(T) cleavage sites. poly(T) tails are required to have
either 8 or more consecutive A's, or if it has a nucleotide other than A, another 8 or
more consecutive A's after that nucleotide is required. Possible internal priming sites
are checked by emmining the generics sequence -10 to +10 ft surrounding the
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cleavage site. If the sequence has six continuous A's or more than 7 A's in a 10 nth
window, it is considered as an internal priming candidate. Poly(Α) cleavage sites
located within a 24 nth window are considered to be generated from heterogeneous
cleavage of ERNA (Paws et al., 2001), and thus are clustered together.
(4) To further ensure the mapping quality, a genuine polyadenylated site must be either
supported by more than one cDNA/EST sequence, or supported by one cDNAJEST
alignment together with at least one polyadenylated signal within the upstream —40
to —1 nth region.

Data generated from the pipeline, including gnomic locations of poly(A) sites,
supporting cDNAJEST, number of cleavage sites, and polyadenylation signal
informated are stored in a relational database using MySQL. Figure 2.2 shows the entityrelationship (ER) schema of the database, which is designed with considerated of the
salability for future expansion of other species. Also in the database are the ortholog
gene information obtained from Homologue database
(http://www.ncbi .nlm.ni h.gov/entrez/query.fcgi ?db=homoiogene), and the tissue/organ

informated of ESNs derived from DNA library files from CBI. Several key data
statistics of the database are summarized in Table 2.1.
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2.3.2 Data Access and Visualization
Data and documentation are available from the polyA_DB web server at
http://polya.umdnj.edu/polyadb . Data can be either downloaded as MySQL flat file

dump or queried through web interface where graphics are dynamically generated using
Bioperl modules (Stanch et al., 2002). The web user interface is interactive and provides
five basic views:
1. Gene view. This view provides a summary of poly(A) site(s) for each queried gene,
their positions relative to the RefSeq(s) and the gnome canting. The gene structure
inferred from the RefSeq(s) and a summary table containing cDNAJEST evidence
and number of cleavage sites are also provided. Links for sequence IDs to CBI
resources are provided whenever possible. Figure 2.3(a) shows a polyA_DB gene
view of mouse TΡM2 gene (b-tropomyosin, LocusLink ID: 22004), with 2 poly(A)
sites and their positions, inferred gene structure, start and stop cordon positions,
number of supporting SST, and number of sites generated by heterogeneous
cleavage.
2.

orthologs view. This view provides a comparison of a pair of human and mouse
ortholog. Figure 2.3 (b) shows an ortholog view of mouse ΤΡΜ2 gene and its human
ortholog (LocusLink ID: 7169). The ortholog view readily revealed that the ortholog
pair is conserved with respect to both their gene structures and polyadenylation
configurations.

3. Signal view. This view provides informated regarding to cis-elements in the
surrounding region of a poly(A) site. Currently, PolyA_DB only documents the PAS
motif (AAUAAA and its 11 single-nucleotide variants) (Beaudoing et al., 2000) in
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the 1-40 ft upstream region of a poly(A) site. Figure 2.3 (c) shows signal views of the
mouse and human TΡΜ2 genes, from which the conservated of signal usage of
poly(A)sitecanb rvld.

4. Evidence view. This view provides detailed alignment evidence from cDNAIEST
sequences, which can be presented by various sorting options including the 3' or 5'
position, Oxon number, cDNAIEST length, and GenBank ID. Α table is also provided,
which lists all supporting cDNAIEST with links to CBI (Figure 2.4).

5. Body view. This view provides tissue/organ informated for poly(A) sites (Figure
2.5).
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Figure 2.3 Views offered at the web interface of polyA_DB. (A) Gene view: Mouse
gene TΡM2 is used as an example. The output includes a pictorial representated of gene
structure and poly(A) sites as well as two summary tables regarding the gene and the
poly) sites. Numbers under each poly) site in the picture are the number of
supporting cDNA/ESTs (which indicates the relative frequency of use of the poly) site)
and the number of heterogeneous cleavage sites. (B) Ortholog view of human and mouse
ΤΡΜ2 genes. (C) Signal views of mouse and human ΤΡΑΜ genes are shown in the upper
panel and lower panel, respectively. The posited of a signal is relative to the cleavage
site, which is set to Ο.
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2.4 Concluseds
PolyA_DB database, a resource for mammalian ERNA polyadenylation is presented
here. This database contains comprehensive informated regarding to polyadenylated,
including poly) sites in the context of gene structure, cDNAJEST evidence for poly)
sites, polyadenylation signals, conservation of polyadenylation configuration between
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orthologs, and tissue/organ informated for poly(A) site usage. The informated presented
in PolyA_DB provides great resources for further large-scale studies to address different
questions of polyadenylation systematically. It is a first step towards the systematic view

_

of mammalian ERNA polyadenylation. PolyA DB will be also of great value to
researchers studying the mechanism of polyadenylation and the gene regulated by
alternative polyadenylation. PolyA_DB will be continuously updated 1) when new
releases of human and mouse gnomes and cDNAJEST data are available, and 2) when
gnome and cDNAJEST data from other species are available for large-scale
polyadenylation studies.

CHApTER 3
CONSERVATION AND GENE ONTOLOGY STUDIES OF
pOLYADENYLATION IN HUMANS AND MICE

3.1 Abstract
Mammalian ERNA polyadenylated is an important cellular process that affects many
aspects of ERNA metabolisms and is tightly controlled by various cis-regulatory
elements and trans-acting protein factors. A great proportion of human and mouse genes
have more than one poly) site and could undergo alternative polyadenylation. Cthers
have only one poly) site. Alternative poly) sites could be situated all within the 3'
most exons or on different axons of a gene. An interesting question to ask is what is the
biological significance of having different polyadenylation configurations such as only
one or more than one poly) sites. Efforts are made here to address this quested by
large-scale conservation and gene ontology studies. Firstly, the conservation of three
types of polyadenylation configurations between human and mouse ontology genes are
studied. Results show that the conservated between humans and mice is statistically
significant, indicating that alternative polyadenylated is a widely employed and
conserved cellular mechanism. Secondly, whether these types of polyadenylated
configurations are associated with genes involved in certain groups of cellular functions
are also emmined. Based on associations of Gene Cntology annotations with different
polyadenylated configurations, statistical tests identified certain functional groups of
genes that are significantly biased towards certain types of polyadenylation
configurations. This large-scale study provides important insights into the systematic
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view of polyadenylation and the regulated of alternative polyadenylated in mammalian
species.

3.2 Introducted
Almost all fully processed mammalian mRNA have a poly) tail at the 3' end, except
for most replication-dependent histone genes Dominski and Marzluff, 1999; Chao et al.,
1999). It is a widely employed cellular process and is interconnected with transcripted
initiation, splicing, and transcripted termination (Calve and Manley, 2003; Proudfoot,
2004). It has been reported that over 29% of human genes have more than one poly)
sites and can undergo alternative polyadenylated, resulting in mRNA with variable ends
(Beaudoing et al., 2000). In fact, the number of genes with alternative poly) sites
documented in PolyA_DB (Chapter 1) are 54% and 32% in humans and mice
respectively. The impact of alternative polyadenylation on protein variants has also been
studied for a number of genes (Edwalds-Gilbert et al., 1997). It is generally believed that
the choice of polyadenylated site is related to tissue types and development stages
(Beaudoing and Gathered, 2001; Edwalds-Gilbert et al., 1997; Chao et al., 1999).
Alternative poly) sites can all situate in the 3'-most exons, giving rise to
mRNA with variable 3' translation regions (3'IJTRs), or in different axons, leading to
mRNA with variable 3' UTRs as well as distinct protein products (Edwalds-Gilbert et
al., 1997). The different types of alternative polyadenylation are referred to as
polyadenylated configurations (Figure 1.2). As UTRs often contain sequence motifs
that are crucial for ERNA stability, ERNA localization, and protein translation, multiple
effects can be implied by the different polyadenylation configurations of genes. A well-

40
known emmple of alternative polyadenylation is the 1gM heavy chain gene (Takagaki et
al., 1996), which has alternative poly) sites on different axons. Choice of using one
poly) site versus another is essential in immune responses by switching from the
membrane-bound form to the secreted form.
Because polyadenylated is a widely employed cellular process in mammalian
systems, it would be expected that the general mechanism is conserved. In fact, several
conservation studies have been done to evaluate the conservated of cis-regulatory
elements and trans-acting factors (Grabber et al., 1999b; Legendry and Gathered, 2003;
Proudfoot, 2004). The result of these conservated studies have greatly facilitated the
advances in in silicon predication methods (Grabber et al., 1999b; Tabasco and Change,
1999). However, whether the polyadenylation configurations of ortholog genes are
conserved has not been evaluated. In addition, there has been no attempt to look at
whether different polyadenylated configurations are utilized as a general cellular
mechanism for certain molecular functions, cellular components, and biological
processes. In this chapter, both issues are addressed in humans and mice. 25,097 human
and mouse genes with 45,565 polyadenylation sites in PolyA_DB (Chapter 1) are used to
study the conservation of polyadenylated configuration between ortholog genes. In
addition, the relationships between gene functions (evaluated in three aspects: molecular
functions, cellular components, and biological processes) and polyadenylated
configurations are addressed. Results show that polyadenylated configurations are
significantly conserved between human and mouse ortholog genes; and that
polyadenylation configurations are associated with certain functional categories specified
by Gene Cntology even after stringent statistical filtering. These comprehensive studies
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shed light on the understanding of the regulated of alternative polyadenylated and
provide systematic views into the roles of niRNA polyadenylation as a fundamental
cellular process in mammalian species.

3.3 Results
3.3.1 polyadenylation Configurateds are Conserved between Humans and Mice
Genes are classified into different types based on their polyadenylation configurations as
delineated in Figure 1.2. Briefly, genes with only one poly) site are classified as type I
genes, genes with multiple poly) sites all in the 3'-most exons as type 11 genes, and
genes with multiple poly) sites located in different axons as type III genes. Thus type I
genes have a single constitutive poly) site, whereas type Π and III genes have
alternative poly) sites. 54% of human genes and 32% of mouse genes have multiple
poly) sites (Table 2.1). To evaluate the conservation of polyadenylated between
humans and mice, whether ortholog genes tend to possess the same polyadenylation
configurations are evaluated. To this end, genes from the three types of polyadenylated
configurations are counted. Counts are then constructed into a contingency table based on
the relations of ortholog pair between humans and mice (Table 3.1).
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Figure 3.1 Conservated of polyadenylation schemes between humans and mice. Z-axis
(vertical axis) is the counts of ortholog pairs. Data is as presented in Table 3.1.

Reciprocal best BLAST hit of protein sequences have identified 7,935 pairs of
ortholog genes in humans and mice (see methods). Because some of human and mouse
genes don't have enough EST evidence for the mapping of their polyadenylation sites,
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only 7,717 out of the 7,935 pair of the ortholog genes are used in the conservation study.
The conservation was evaluated with a Pearson χ2 test applied to the contingency table
(Table 3.1). The devalue for the Pearson χ2 test is 2.0χ10 -132 , suggests that the
conservation of polyadenylated configuration between human and mouse ortholog are
statistically significant (Figure 3.1). Overall, 51% (3,929 out of 7,717) ortholog gene
pairs have conserved polyadenylation configurations. Comparing to expected values
computed based on a hypergeometric distribution (see method), number of ortholog
genes that are conserved in polyadenylation configurations are all more than 1.2 fold
above the corresponding expected values (Figure 3.2). Taken together, these results
indicate that alternative polyadenylated is an evolutionarily conserved cellular process
between human and mouse ortholog genes.

44

3.3.2 Gene Ontology Study of polyadenylation Configurations
To address the question of whether polyadenylation configurations are associated with
certain functional groups of genes, the relationships between gene functions, as indicated
by gene ontology (GC), and the polyadenylation configurations were studied. To identify
evolutionarily conserved functional groups, only those ontology genes that have
conserved polyadenylation configurations between humans and mice are used (Figure
3.1). Functional groups of genes are categorized as biological process (BP), cellular
component (CC), and molecular functed (IF) and are derived from the extensive
mapping of LocusLink project at CBI (Pruitt and Maggot, 2001). Each gene is
identified by a LocusLink ID and is annotated in association of several GO terms based
on the gene function. Therefore, associations of certain GC terms to polyadenylation
configurations are established through the polyadenylated configuration types of
associated genes. Each GC term will be voted by the number of genes in each type of
polyadenylation configuration. A total number of 7,315 GC terms belonging to the three
categories (BP, CC, and IF) were studied. To evaluate whether a GC term is statistically
significantly biased towards certain type of polyadenylation configurations, Fisher's
Exact test was applied to each GC terms. Stringent false positive rate control was applied
using a Benjamini and Hochberg method (Benjamin and Hochberg, 1995).
In total, there are ten GC terms significantly associated with certain
polyadenylated configurations. Genes related to cell surface receptor-linked site
transaction (biological process), extracellular genes (cellular component), and site
transducer activity (molecular function) are found to be disproportionately associated
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with the type I constitutive polyadenylation (Table 3.2). Genes encoding intracellular
proteins (cellular component), proteins involved in intracellular protein transport
(biological process), and proteins having protein transporter activity (molecular
functions) are found to be disproportionately associated with alternative polyadenylation
(Type Ilk and Type TIakentog)hr.,ismantcelurpoigstnd
have constitutive polyadenylation sites, whereas intracellular protein proacts are biased
to having more than one poly) sites, and thus may be more susceptible to the regulation
of alternative polyadenylated. In addition, when looking at Type III genes separately,
disproportional associations of genes whose protein proacts are located in the nucleus
and have RNA binding activities appear to be statistically significant. Because Type Ι
genes have more than one poly) sites located on different axons, this indicates that the
regulation of these genes by alternative polyadenylation might be related to splicing.
The results are shown in Table 3.2. Ten GC terms in three categories (Biological
Process, Cellular Component and Molecular Function) were shown to have
disproportional statistically significant correlations with different types of
polyadenylated configurations (Table 1.1). For each GC term, GC ID and annotation are
presented on separate lines. A Devalue from Fisher's exact test is provided for each GC
term in humans and mice, separately. The lower the Devalue, the more significant the
association is between this GC term and the corresponding tested polyadenylation
configuration. G0:0006886 (intracellular protein transport) is associated with both
G0:0046907 (intracellular transport) and G0:0015031 (protein transport) through an "is
a" relationship (for details see Materials and Methods). Multiple testing adjustment using
the Benjamanini and Hochberg method was applied to the selected of significant GC
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terms. The numbers of genes associated with a GC term are listed in parentheses in the
order of the three types of polyadenylation configurations, i.e. type I, type Ilk, and type III.
For emmple, (171, 37, 3) stands for that 171 type I genes, 37 type gIensladk3typH
genes are annotated as cell surface receptor linked site transaction, identified by
G0:0007166.
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3.4 Materials and Methods
3.4.1 Conservation Study of Human and Mouse Ontology Genes
Human and mouse ortholog genes were obtained from NCBI Homologue database
(ftp://ftp.ncbi.nih.gov/pub/HomoloGene/) . Cnly reciprocal best BLAST hits of protein

sequences (7,935 ortholog pairs) were used as human and mouse ontology genes.
Person's Chi-square test was used to test the significance of the conservation of
polyadenylation configurations between ortholog pairs. R program (http://www.rproject.org/) was used to conact statistical test and compute expected values by the Chic-

square test function in the R paccoge. The estimation of expected values based
hypergeometric distributions are calculated through the Chi-square test moale in the R
paccoge.

3.4.2 Gene Ontology Analysis
Gene ontology (GC) was downloaded from Gene Cntology Consortium website
(http://www.geneontology.org/). Gene annotations using established GC terms were

obtained from the LocusLink database of CBI (Pruitt and Maggot, 2001). The full list
of GC terms are analysed in three categories, namely Biological Process (BP), Cellular
Component (CC), and Molecular Functed (IF). Because GC is represented in a tree
structure (Ashburner et al., 2000), for each GC term, all associated GC terms were found
by a recursive method which searches the whole gene ontology tree for related entries
through either "is a" or "part of" relationship. A total number of 7,315 GC terms (3,607
BP, 690 CC, and 3,039 CIF) were found to be associated with 9,057 human and 7,700
mouse genes. Fisher's Exact test using 2 by 2 table was applied to assess the bias of
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polyadenylated configuration for each GC term. The Benjamin and Hochberg method
was applied to eliminate false positives generated as a result of multiple testing
(Benjamin and Hochberg, 1995). Briefly, consider i GC terms each with a Fisher's
Exact test p-values, and a 0.05 as a significant cutoff, following proceares are applied:
1. Sort devalue for each GC terms from smallest to largest, denote the ith smallest
p-values by p(i) for each i between 1 and m.
2. Starting from the largest p-values p.m), compare p.i) with 0.05 x i/m, continue as
long as p(i) > 0.05 x ism.
3. Let i be the first time when p(i) is less than or equal to 0.05 x k/m, and then
declare GC terms corresponding the smallest i p-values are significant.
Two sets of test were carried out independently, which are the test of biased association
of GC terms with constitutive poly) sites (Type I) versus alternative poly) sites
(Type II and Type III), and the test of biased associated of GC terms with poly) sites
on different axons (Type III) versus others (Type I and Type II). When testing
constitutive poly) sites, two columns in fisher 2 by 2 tables are constitutive
polyadenylated and alternative polyadenylated, and two rows are "having the GC term"
and "not having the GC term". The test for type III gene was carried out in a similar
manner except that one column is "is a type III gene", and the other is "is not a type III
gene".

3.5 Conclusion and Discussion
In summary, conservation and Gene Cntology studies were carried out to evaluate
polyadenylation configurations of genes in humans and mice on a system level. Results
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show that polyadenylation configurations appear to be highly conserved between human
and mouse ortholog genes; and that statistically biased associations of GC terms and
polyadenylated configurations suggest that alternative polyadenylation may be utilized
as a general cellular regulation scheme.
Although the polyadenylated configurations are shown here to be highly
conserved between human and mouse genes, it is expected that when more EST data
(especially mouse EST data) become available, the conservation will be even more
significant. As shown in PolyA_DB (Chapter 1), 54% of human genes have alternative
poly) sites, whereas only 32% of mouse genes have alternative poly) sites. The
difference is mostly ae to the limited supporting EST's from mice (Table 2.1). As EST
data is accumulating in a fast rate, it will be more desirable to evaluate conservated
among more species when more EST data are available (Table 3.3).
Edwalds-Gilbert et al. have detailed alternative polyadenylation into three types:
1) tandem poly) sites, 2) coupled with composite iiiiterminal exons, and 3) coupled
with skipped exons (Edwalds-Gilbert et al., 1997). Genes with tandem poly) sites are
the same as Type III gene classification. However, because the last two types of EdwaldsGilbert et al. are actually results from two distinct mechanisms of alternative splicing, we
collectively called them type III genes, where alternative polyadenylated maybe related
to splicing. Interestingly, GC study found that RNA binding proteins are
disproportionately associated with the type III polyadenylated configuration, indicating a
self-regulation mechanism of these genes on ERNA level.
It is also desirable to study the association of different PAS Remmers with
polyadenylation configurations. However, associated of AAUAAA and its 11 single-
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base variants identified by large-scale bioinformatics study doesn't show meaningful
statistically significant associations. This is likely ae to two reasons: 1) the high
dominant occurrence of AAUAAA; 2) association being specified by the spatial
arrangement of AAUAAA, GEnrich element, USE, and other auxiliary elements. Future
work needs to put PAS, DICE, USE, and other auxiliary elements into context to study
their associations with different polyadenylation configurations, probably focusing on
tissue- or disease specific regulations.

Alternative transcription initiation, alternative splicing, and alternative
polyadenylation are the major mechanisms that can proace different transcripts from the
same gene in mammalian systems. It has been estimated that about 18% of mammalian
genes have alternative promoters (Landry et al., 2003; Trinklein et al., 2003) and about
35-55% have alternatively spliced forms (Brett et al., 2000; Kan et al., 2001; Modrek et
al., 2001). The estimation of alternative polyadenylation genes is about 32-54% in this
study, which is comparable to that of alternative spliced genes. The lower number of
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genes with alternative promoters could be attribute to the intrinsic bias of ESTs toward
the 3' end of transcripts. As a result, only limited amounts of full-length cDNAs are
usually used to estimate alternative transcripted initiation events.
Both alternative polyadenylation and alternative transcription initiation can be
coupled with alternative splicing. To date, there is no genome-wide conservation study of
different types of configurations of alternative transcription initiation that are comparable
to the conservation study of alternative polyadenylated discussed in this chapter.
However, several indiviaal cases have indicated that such conservation exists between
humans and rodents (Landry et al., 2003).
The amount of alternative splicing has been indicated to be comparable among
seven different eukaryotes, with no significant differences between humans and other
animals (Brett et al., 2002). Several conservated studies have been conacted in recent
years, mostly focused on conservated between humans and mice. Because alternative
splicing could be very complicated given various combinations of different mechanisms
including exons skipping, alternative 3' splice sites, alternative 5' splice sites, and intro
retention, there has been no established splicing configurations as comparable to the
polyadenylated configurations studied here (Sugnet et al., 2004). Instead, conservation
of alternative splicing between human and mouse gnomes is often studied by emmining
alternatively spliced cassette axons (Resch et al., 2004; Yeo et al., 2005) or by comparing
sequence features at splice junctions (Kan et al., 2001; Thanaraj et al., 2003). The
conservated results estimated from these studies are generally in agreement with each
other. Kan et al and Yeo et al estimate that about 10-11% of alternative splicing events
are conserved between humans and mice. Thanaraj et al estimates 15% of alternative
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spliced junctions are conserved between human and mouse gnomes. These estimations
are much lower than the conservation of alternative polyadenylation configurations
(51%), suggesting that alternative polyadenylated is more conserved than alternative
splicing. However, this is somewhat perplexing because alternative splicing events are
expected to be under more selective pressure than alternative polyadenylated ae to the
fact that alternative splicing events are more likely to result in different protein products
(Resch et al., 2004). The low conservation of alternative splicing could be a result of
limited ESTs that can be used in conservated studies when dealing with multiple species,
or could be a result of overrepresentation of aberrant or species-specific-diseased
splicing forms in EST libraries (Sore et al., 2004). Nonetheless, the high conservation of
alternative polyadenylated comparing with alternative splicing does indicate that
regulatory sequences on transcripts are very important aring evolutionary selections.

CHApTER 4
TISSUE-SpECIFIC ALTERNATIVE pOLYADENYLATION IN HUMANS

4.1 Abstract
Alternative polyadenylation is one of the widespread mechanisms in eukaryotic cells that
can be regulated to proace a variety of transcripts from a single gene. More than 50% of
genes in humans have multiple polyadenylation sites, the use of which may vary in a
tissue-specific fashion. Using a large-scale computational approach, stomach, retina,
ovary, and lung show tissue-specific differential usage of strong and weak poly) sites.
Based on the three types polyadenylation configurations, nervous system, bone marrow,
uterus, ear, braiii/CNS, pancreatic islet, and ovary are shown to have tissue-level
differential usage of poly) sites in type 11 genes (alternate poly) sites all located in
the 3' most exons); cerebrum, eye, prostate, skin, retina, esophagus, soft tissue, and lung
have tissue-level differential usage in type IlI genes (alternate poly) sites locate in
different axons); whereas placenta, retina and blood/whole blood show tissue-level
differential usage in both types. In addition, positional preferences in these tissue-level
differential usage of poly) sites are observed. By exploring available microarray
expression data, analysis of a set of 20 known polyadenylation-related protein factors
identified low concordance of ERNA expression levels in brain tissues compared to other
tissues. Examining ERNA levels of these protein factors revealed that PC and CstF64tau message levels are consistently higher in brain tissues, while PCB and UlA
messenger levels are consistently lower in brain tissues, compared to other tissues.
Finally, enriched cis-regulatory elements in poly) sites expressed in brain tissues
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suggest that interactions between trans acting factors and cis-regulatory elements may be
-

very important in tissue-level alternative polyadenylated regulation in brain.

4.2 Introduction
Eukaryotic gene expression could be extremely complicated along the path from a gene
to a protein proact. At the transcription level, in addited to alternative initiation and
alternative splicing, alternative polyadenylation is also frequently used to regulate gene
expression by proacing ERNA with different 3'IJTR or protein informs in a tissue- or
tissue-specific fashion (Lou et al., 1996; Takagaki et al., 1996). The great contribution of
alternative polyadenylated to the complexity of ERNA species underlies the significance
of understanding its regulation.
More than 50% of human genes have multiple poly) sites, the differential usage
of which will result in different protein proacts or mRNAs with different 3'IJTRR. Under
different physiological conditions, some poly) sites might be used more often (strong
poly) sites) than others (weak poly) sites). The 3'-most poly) sites are believed to
be stronger than those located to the 5' proximal (Beaudoing et al., 2000). It is generally
believed that such selected of strong or weak poly) sites and/or possible positional
preference maybe regulated in a tissue- or disease-dependent fashion (Beaudoing and
Gathered, 2001; Edwalds-Gilbert et al., 1997), and that both tissue-specific trans-acting
protein factors and corresponding cis-regulatory elements are responsible for the
regulated of differential selection of poly) sites.
The availability of generics sequences and large amount of DNA and expressed
sequence tags (ESTs) has enabled large-scale study of alternative polyadenylation in the
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mammalian transcńptome (Beaudoing et al., 2000; Beaudoing and Gathered, 2001;
Gautheret et al., 1998; Legendry and Gautheret, 2003; Tian et al., 2005; Change et al.,
2005) as well as other eukaryotic species (Graber et al., 1999a; Grabber et al., 1999b). All
of these large-scale analyses are based on aligning EST sequences to the gnome. As a
result, strong and weak poly) sites can be identified by the number of supporting SST.
A set of tissue-specific biases of polyadenylation sites has also been identified
(Beaudoing and Gathered, 2001). However, several issues of tissue-specific alternative
polyadenylated events have not been comprehensively addressed, these include but not
limited to: 1) Which tissues have biased usage of strong versus weak poly) sites? 2)
Does tissue-specific alternative polyadenylated have positional preference? 3) To what
extent do expression levels of known polyadenylation-related protein factors account for
tissue-specific alternative polyadenylation? 4) And whether there are biased cisregulatory elements in the surrounding sequences of tissue-specifically used poly)
sites?
Efforts were described here of using computational approaches to study tissuesspecifics alternative polyadenylation events on a large-scale. Tissue-specific biased usage
of strong or weak poly) sites are observed. The results presented here also suggest
positional preferences in the differential usage of poly) sites. Analyzing microarray
expression data of polyadenylation-related protein factors identified low concordance of
expression levels in brain tissues. In addition, polyadenylation-related factors that show
consistently higher or consistently lower ERNA levels in brain tissues are identified.
Finally, cis-elements study in tissue-specifically used poly) sites reveals over- and
underrepresented motifs in specific sequence regions surrounding polyadenylation sites.
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Together, the data distinguished several tissues show tissue-specific regulation of
alternative polyadenylated and positional effects, and identified candidate cis-regulatory
elements and trans-acting factors that may play important roles in tissue-specific
alternative polyadenylated in humans.

4.3 Results and Discussion
4.3.1 Tissue-Specific Usage of Strong and Weak poly) Sites
The processing efficiency of polyadenylated has direct impact on the fate of mRNAs,
and eventually affects their protein proacts. Abnormal processing efficiencies can lead
to human diseases such as thrombophilia (Gehring et al., 2001). PolyA_DB has shown
that more than 50% of human genes have multiple poly) sites and may undergo
alternative polyadenylation (Chapter 1). The relative strengths of poly) sites of these
genes may be different and the usage of alternate sites may be regulated in a tissue- or
development-specific fashion (Beaudoing and Gautheret, 2001; Edwalds-Gilbert et al.,
1997). For emmple, regulated of 1gM heavy chain secreted form and membrane form
aring B cell differentiation is achieved by switching the usage between the upstream
weak poly) site and the downstream strong poly) site (Takagaki and Manley, 1998).
With the availability of a large amount of EST data, the polyadenylated
processing efficiency can be assessed by the number of ESTs supporting the usage of the
corresponding poly) sites (Legendry and Gautheret, 2003). The first goal is to identify
tissues that show significantly biased usage of strong or weak poly) sites. To this end,
22,865 poly) sites from 7,524 alternatively polyadenylation human genes in PolyA_DB
(Chapter 1) are classified into strong and weak sites by comparing their supporting EST
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counts. In consistency with the strategies employed in constructing of PolyA_DB,
supporting EST are those poly(A)/poly(T)-tailed ESTs after cleaning out possible
internal priming candidates. For each gene, a poly) site with more than 75% of
supporting EST is classified as a strong site (3,711 sites), while poly) sites with less
than 25% of supporting ESNs are classified as weak sites (5,663 sites). It is important to
point out that since some DNA libraries are normalized, EST counts in these libraries
cannot be used to reflect polyadenylation efficiency for genes. Therefore, only EST
counts from non-normalized libraries are used to infer polyadenylation efficiencies (See
method for classifying normalized and non-normalized DNA libraries). In addition,
since this type of analysis relies on a large number of observations to ensure the
soundness of statistics, only genes with at least four poly(A)/poly(T)-tailed supporting
EST were used in this classificated step.
The designated tissue types of ESTs were obtained from the extensive annotated
of Yeo et al (Yeo et al., 2004), based on which, 5,929 out of 9,170 DNA libraries in
PolyA_DB (Chapter 1) can be classified into 48 tissue types. We assess the usage of
strong and weak sites by allowing genes in each tissue type to vote for the usage of
poly) sites based on the number of supporting ESTs. To account for the difference of
gene expression levels so that votes are not biased to highly expressed genes, votes for
the usage of strong or weak sites are normalized by dividing total number of supporting
EST for each gene (see method). The tissue-level usage of strong or weak poly) sites
in each tissue can therefore be measured by summing up votes of all genes studied in the
tissue. Based on our classification criteria of strong and weak sites, most tissues are
expected to have a linear correlation between votes for strong poly) sites versus weak
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poly) sites (Figure 4.1, Chi-squared = 0.9758). However, tissues that have differential
usage of strong and weak poly) sites will show poor correlations. As shown in Figure
4.1, stomach, retina, ovary, and lung clearly deviate from the 95% confidence intervals
(orange lines), with stomach, ovary, and lung biased to the usage of strong poly) sites
and retina biased toward the usage of weak poly) sites, suggesting a tissue-level
alternative usage of poly) sites.
However, pineal gland, muscle, prostate, and eye have only shown marginal
deviations (Figure 4.1, black spots). To evaluate the statistical significance of the
observed tissue-level biased usage of strong and weak poly) sites, Chi-square tests are
further performed on all tissues (see method). To account for the different number of
supporting EST across human tissues, votes of usage of strong and weak sites are
normalized by the total number of studied EST in each of the corresponding tissue
before statistical tests. As expected, stomach (p=0.034), retina (p=0.022), ovary
(p=0.019), and lung (ρ=0.004) all give significant p-values (Figure 4.1, in brackets),
further supporting a tissue-level bias of strong and weak poly) sites usage. However,
Pearson χ2 test p-values of marginal tissues are not significant.
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Figure 4.1 Tissue-specific strong and weak poly) site usage. Each filled spot or open
circle is a tissue type identified by coordinates of vote score for strong sites and vote
score for weak sites. Red line is a linear fit with chi-squares = 0.9758. Filled blue spots
are tissues with significant Pearson χ2 test devalue (p <= 0.05). Filled black spots are
marginal tissues without significant χ2 test devalue. Filled spots are labelled by tissue
names and devalue in brackets.

4.3.2 Positional Preference of Tissue-Specific Alternative Polyadenylation
To address whether there are positional preferences for alternative polyadenylation on a
tissue-level, tissue-specific alternative poly) site usage is evaluated based on the
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relative positions of poly) sites on transcripts. To this end, genes are first classified into
three types based on their polyadenylation configurations (Chapter 1). Briefly, genes with
only one poly) site are classified as type I genes, genes with multiple poly) sites all
in the 5'-most exon as type II genes, and genes with multiple poly) sites located in
different axons as type III genes. To further study if there is a positional preference of
tissue-specifc usage of alternate poly) sites, poly) sites in type II genes are
classified into 2F (the 5'-most poly) site), 2L (the 3'-most poly) site), and 2Μ
(middle poly) sites between 2F and 2L); and poly) sites in type III genes are
classified into 3U (poly) sites located upstream of the 5'-most exon) and 3D (poly)
sites located in the 5'-most exon).
To look for tissue-specifc usage of the 3 types of alternate poly) sites in type II
genes (2F, 2M, and 2L) and the 2 types of alternate poly) sites in type III genes (3U
and 3D), a voting strategy similar to that was described above for strong and weak
poly) sites study was applied to type II and type III genes, except that votes now reflect
the usage of sites classified by the relative positions located in or upstream of the 3'-most
exon, i.e. 2F, 2M, and 2L for type II genes, and 3U and 3D for type III genes. Pearson χ2
test are then applied to the usage of different types of sites for each tissue, the expected
votes are derived from the median votes of all tissues (see method). Statistical
significantly disproportional usage of poly) sites are observed in both type II and type
III genes (Table 4.1, Table 4.2).
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Table 4.1 Positional preference of tissue-specific usage of poly) site in type III genes.
(Observed Expected) /
TISSUE
Blood/Whole

Gene EST

Supporting EST vote

Normalized vote

2F

2F

value

2F

2L

2Μ

2L

94.15 0.45

0.20

0.35 8.19E-05

0.35 -0.02 -0.25

160.77

303.12 0.38

0.21

0.40 9.98E-04

0.15

2L

120.39

52.46

754 1987 290.11

797

Expected

2Μ

2Μ

267

Χ2 test P

Blood
Ovary

0.06 -0.14

Retina

1106 2021

419.34 213.41

473.26 0.38

0.19

0.43 3.52E-03

0.14 -0.04 -0.09

Placenta

1428 3066 511.66 315.95

600.39 0.36

0.22

0.42 1.57E-03

0.07

Uterus

1607 4300 487.28 365.07

754.65 0.30

0.23

0.47 6.67E-03 -0.09

0.13

0.00

0.10 -0.10

Brain/CNS

794 1969 239.44

147.82

406.74 0.30

0.19

0.51 4.12E-02 -0.10 -0.07

0.09

Bone Marrow

554 1407

136.53

261.47 0.28

0.25

0.47 5.92E-03 -0.16

0.23

0.01

Pancreatic Islet 1003 3765 275.13 216.25

511.61

0.27

0.22

0.51 5.03E-04 -0.18

0.07

0.09

Ear

534 1272

Nervous

116

137

156.00

129.33

134.22

270.45 0.24

0.25

0.51

1.90E-05 -0.27

0.25

0.08

23.67

30.33

62.00 0.20

0.26

0.53

1.10E-02 -0.39

0.30

0.14

1. Expected usage: 2F: 0.33; 2Μ: 0.20; 2L: 0.47.

Table 4.2 Positional preference of tissue-specific usage of poly) site in type III genes.
(Observed - Expected) /

Supporting EST
TISSUE
Blood/Whole

Gene EST
172

380

3U
37.22

Expected

Normalized vote

vote
3D

3U

3D

Χ2 test P value

3D

3U

134.78

0.22

0.78

3.09Ε-05

0.88

-0.11

Blood
Retina

777 1391

167.60 609.40

0.22

0.78

1.46E-18

0.87

-0.11

Eye

955 2271

193.63 761.37

0.20

0.80

2.00E-17

0.76

-0.10

Esophagus
Placenta

78

14.00

59.00

0.19

0.81

3.99E-02

0.67

-0.09

1008 2164

192.25

815.75

0.19

0.81

5.09E-14

0.66

-0.09

73

Skin

540 1485

99.00 441.00

0.18

0.82

6.59E-07

0.59

-0.08

Prostate

478 1269

70.76 407.24

0.15

0.85

2.38E-02

0.29

-0.04

Lung

676 1770

97.92 578.08

0.14

0.86

1.52E-02

0.26

-0.03

Soft Tissue

152

202

9.00

143.00

0.06

0.94

3.10E-02

-0.49

0.06

Cerebrum

64

79

2.00

62.00

0.03

0.97

3.56E-02

-0.73

0.09

1. Expected usage: 3U: 0.12; 3D: 0.88.
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Το further evaluate the positional preferences in observed significant tissues, their
votes are compared with expected usage votes computed from median values of votes
across all tissue types (Figure 4.2A and 4.2B). Increased usage of 5'-mοst poly) sites
(2F) are observed in placenta, retina, blood/whole blood, and ovary, with the decreased
usage of 5'-mοst poly) sites (2L), suggesting a shift of usage from 3' to 5' poly)
sites. However, in bone marrow, uterus, ear, braiiiiCNSS, nervous system, and pancreatic
islet the preference is opposite, with an decreased of usage of 5'-mοst poly) sites (2F)
and increased usages toward the 3' proximal poly) sites (2M and 2L), suggesting s
shift of usage from 5' to 5' poly) sites. Similarly, placenta, eye, prostate, skin,
esophagus, retina, blood/whole blood, and lung show strong increase in the usage of
poly) sites located upstream of the 3' -most Oxon (3U), whereas cerebrum and soft
tissue show strong decrease of these poly) sites but increase usage of poly) sites
toward the 3' proximal of the ERNA (3D). It is also readily discernable that placenta,
retina, and blood/whole blood show positional preferences of usage of poly) sites in
both type II and type III genes, and more interestingly, the preferences are all toward the
5' most poly) sites (2F and 3U). Together, these observations suggest that there are
tissue-level positional preferences for the usage of poly) sites, such preferences can
affect only type II genes, only type III genes, or both type aIndtylpeIkgs.Sic
these tissue-specific preferences are observed on a global rather than tissue-specific level,
the regulation of these preferences may be achieved by coordinating between a set of
non-gene-specific cis-regulatory elements and a set of trans-acting protein factors, the
expression level of which might be regulated in a tissue-specific manner.
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Figure 4.2 Tissue-specific positional preferences of poly) site usage. Plotted in both
panels are percentage changes relative to expected usage: (observed — expected) /
expected. A. Tissue-specific positional preferences of type TBgIiseul-npkcf.
positional preferences of type Ill genes.
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4.3.3 Differential Expression of polyadenylation Related protein Factors among
Tissues
Inspired by Yeo et al (Yeo et al., 2004), to further address if there are tissueespecific
expression of trans acting factors that might regulate the observed tissueespecific
e

alternative poly) site usage, available microarray expression data was analyzed to
explore the differences of expression levels of a set of 24 polyadenylationerelated factors
(Table 4.3) across different tissue types. To date, there are about 41 genes coding for
proteins showing evidence of involvement in the polyadenylated process (for the full list
Table 1.1), of which this set of 24 factors are known or have been suggested to have
regulatory roles in nuclear polyadenylation (for references, see Table 4.3).
Available ERNA expression data were obtained from two independent
microarray studies (Su et al., 2002; Su et al., 2004). Cne set of data is from the chip type
ΗGeU95A, and the other set of data is from the chip type ΗGeU133A. The two set of
independent data were analyzed separately, the comparison of which can be used to
validate each other. Therefore, only a set of 25 tissue types that exist in both datasets
were selected in this tissueespecific alternative polyadenylation transeacting factor study.
The goal is to find tissues that show low concordance of expression levels of transacting
polyadenylated factors compared to most other tissues, and compare the results with the
set of tissues that show positional preferences. Microarray data are first normalized to
75th percentile within each tissue. Cut of the 24 polyadenylationerelated factors (Table
4.3), 20 of them were represented on both ΗGeU95A and ΗGeU133A chips (see Table
4.3 for supporting probeesets). Therefore, an expressionelevel vector of 20
polyadenylationerelated factors can be obtained for each human tissue. Pearson proact
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moment correlation coefficients (r) were computed between all pairs of 25 tissues to
evaluate the variations of expression in polyadenylation-related factors. If the relative
ERNA expression levels across this set of polyadenylation-related factors have a low
concordance between two tissues, a low value of r is expected, whereas if the relative
ERNA expression levels across this set of factors are similar, a high value of r is
expected. Tissues are then clustered based on revalue obtained from both ΗGeU95A data
and HG-U133A data.
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The revalue between pairs of tissues computed is plotted as a heat-map in Figure
4.3, the clustering results of tissues are shown on top of the heat-map. Most tissues show
high concordance in polyadenylationerelated factors expression (r > 0.75). However, a
distinct cluster (average revalue 0.87 within the cluster) of brain tissues (Amygdala,
Thalamus, Caudate Nucleus, Fetal Brain, and Whole Brain) shows a low degree of
concordance in the relative ERNA expression levels of polyadenylationerelated factors
with most other 20 tissues (average devalue 0.55). As shown before in Chapter 4.3.2,
braiiiiCNS and cerebrum show statistical significant positional preference in poly) sites
usage (Table 4.1, Table 4.2, Figure 4.2). In addition, four other tissues in our microarray
data have also shown significant positional effects of poly) site usage. These are lung,
ovary, placenta, and prostate. As placenta, lung, ovary, and prostate appear to have
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positional preference toward the 5' poly) sites (2F and 3U), whereas CANS (central
nervous system) show preference toward the 3' poly) sites, when examining devalues
of microarray data between the set of brain tissues with placenta, lung, ovary, and
prostate, the correlations between the two groups are found to be very poor, with a mean
devalue of 0.41 (Figure 4.3, green blocks). Examining message levels of specific
polyadenylation-related factors in the set of brain tissues in both ΗG-U95A and HGU133A datasets, relative expression levels of PTB (polypyrimiding tract-binding protein)
and UlA (small nuclear ribonucleoprotein polypeptide A) are consistently lower in brain
tissues than in other tissues, whereas the relative expression levels of PC (transcripted
coactivator PC) and CstF64etau (cleavage stimulatory factor subunit 2 tau variant) are
consistently higher in brain tissues (Figure 4.4, Table 4.4). However, comparisons of
expression levels between brain tissues and other tissues for other 16 factors don't show
such bias in both ΗG-U95A and HG-U133A datasets (Figure 4.5).
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Figure 4.3 Correlation of PERNA expression levels of 20 polyadenylation-related factors
(Table 4.1) across 25 huEan tissues (upper diagonal: data froE HG-U133A et al.,
2004), lower diagonal: data from HGeU95A(Su et al., 2002), HG-U133A and HG-U95A
data are analyzed separately). Based on a scale displayed on top of the figure, sEall
squares are colored to represent the extent of the correlation between PERNA expression
patterns of the 20 genes in each pair of huEan tissues.
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PCB is a repressor of ERNA splicing (Chan and Black, 1997; Wollerton et al.,
2004) and it has been shown that in brain there are high levels of alternative splicing
(especially exon-skippings) (Leo et al., 2004), which is consistent with our observation
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of a low message level of PTB in brain tissues. It has also been shown that PCB can
moalate polyadenylated efficiency and this is probably by competing with CstF64
(cleavage stimulatory factor subunit 2, 64ΚD) for binding to DICE (downstream sequence
element) (Castelo-Branco et al., 2004). UlA can increase polyadenylation efficiency by
interacted with both USE (upstream sequence element) and CPS (Lutz and Alwife,
1994; Lutz et al., 1996). An RNA-UlA protein complex containing two UlA molecules
can also auto-regulate its proacted by inhibition of PAP activity (Gunderson et al.,
1994; Gunderson et al., 1997). Furthermore, PC4 can regulate polyadenylation by
protein-protein interactions with CstF64 (Calve and Manley, 2001). CstF64-tau is a
variant of CstF64 (75% of sequence identity) that is highly expressed in brain and testes
(Wallace et al., 1999). Sequence analysis shows that the C-terminus KBD (RNA binding
domain) and C-terminus 63 amino acid of putative PC4 binding domain of CstF64 and
CstF64-tau are highly conserved (>95% of sequence identity, Figure 4.6), indicating
CstF64-tau is also possible to interact with PC. More interestingly, CstF64-tau gene
contains no intron and hence doesn't require mRNA splicing, whereas CstF64 gene has
13 introns and could potentially be regulated at mRNA splicing level, given the unusually
high level of alternative splicing in brain tissues (Yeo et al., 2004). Finally, on a similar
line of CstF64-tau as a brain-specific counterpart of CstF64, PCB protein also has a
brain-specific counterpart PTB (Ashy and Arabowski, 1997; Markovtsov et al., 2000).
Both nPTB and CstF64-tau message levels are consistently higher in brain tissues
compared to other tissues, whereas PCB message levels are consistently lower and there
is virtually no difference in CstF64 message level (Figure 4.7). Taken together, this
evidence suggests that the observed unusual expression levels of these 4 polyadenylation-
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related factors in brain tissues Eight contribute at least in part to the tissueelevel
positional effect of poly) site usage.

Figure 4.6 Protein sequence alignment of huEan CstfF64 (CSTF2T) and CstF64etau
(CSTF2T).

4.3.4 Over- and Underrepresented Motifs in Poly(A) Sites that are TissueSpecifically Used.
The well-established paradigE in the regulation of alternative polyadenylation is that

trans-acting factors and ciseregulatory elements usually work in concert. The
observations of positional effects of alternative polyadenylation and unusual expression
levels of several polyadenylation-related factors in brain tissues had prompted a look into
candidate ciseregulatory eleEents in brain tissues. Based on known facts of sequence
deterEinants in the poly) sites vicinity regions (as discussed in Chapter 1), a poly)
site vicinity sequence was separated into four regions relative to the cleavage site:
upstream 40 nt, where AAIJAAA/AIJUAAA are usually located, downstream 40 nt,
where G/IJerich eleEents are usually located, 60 nth further upstreaE where USE Eaybe
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located, and 60 ft further downstream where other auxiliary elements might be located
(Figure 6 top, labeled as region "a" to "d" from 5' to 5', also see Figure 1.1). To identify
cis-regulatory motifs in brain-specific poly) sites, an approach was taken that is similar
in spirit to the computational method described by Fairbrother et al. (Fairbrother et al.,
2002). Briefly, all 4,096 (4 6 ) Remmers were assigned two scores: AU, the scaled
difference between the frequency of occurrence in the sequence regions (region "a" to
"d") from poly) sites used in brain and those that are from poly) sites not used in
brain; and APB, the scaled difference between the frequency of occurrence in the vicinity
of poly) sites and the frequency of occurrence to the distal of poly) sites (see
method). Therefore one dimension is to identify brain-specific hexamer, and the other
dimension is to identify polyadenylation-specific Remmers. The four regions (region "a"
to "d") were analyzed separately. Each one of the 4,096 hexamers was then represented on
a two-dimensional space identified by coordinates AU and APB (Figure 4.8). Using a
cutoff of 2.5 that corresponds to a devalue of about 0.01 on each dimension, over- and
underrepresented hexmers were identified. Because the cutoff on each dimension is 0.01,
the overall devalued is 10 4 , which means number of false positive hexamer identified by
this criteria should be less than one (4,096 x 10 4). Significant hexamer identified were
then clustered based on their nucleotides similarities. Sequence logos (Schneider and
Stephens, 1990) were used to build motifs from a multiple sequence alignment of those
tightly clustered Remmers (See method).
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Figure 4.8 Identify brain-specific polyadenylation related hexamers. All hexaEers are
plotted in the corresponding subregions around poly) sites. Plot on xeaxes are Δυ
values, which is coEparing poly) sites used in brain and those that are not used in
brain, on y-axes are ΔΡ values, which is coEparing poly) sites vicinity sequences to
those distal regions. The cutoffs are both 2.5 as indicated by dashed lines, significant
hexaEers are depicted as "*", others are depicted as ".".

Nine sequence Eotifs are identified that are significantly overrepresented and
three sequence motifs are identified that are underrepresented in poly) sites that are
brainespecifically utilized (Figure 4.9). First of all, UUCU and UUCU are overe
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represented in region "a" (USE region) and region "c" (DICE region), which are known to
be PTBebinding sites (Castelo-Branco et al., 2004; Garcia-Blanco et al., 1989; Wollerton
et al., 2004). In addition, 3 A/Enrich elements were observed in region "c"
(UUGUGUGUU, UAAUUGU) and region-d" (UGUGUGU), which are known
downstream elements for enhancing polyadenylated efficiency. Furthermore, an
A/Enrichelmt(UA/IJ)isoverpntdgi-,whcser
polyadenylation signals (AAUAAA or AAUAAA) are located. Very interestingly, the
A/Enrich element very much represents a randomly arranged polyadenylation signal (two
copies of AAUAAA), which has been shown before to decrease the usage of upstream
poly) sites (Denote and Cole, 1988). Finally, a motif of AAAUGU sites was overrepresented in region "b" of brain-specific used poly), which is know to be an eIF-5α
binding site (Xu and Chen, 2001; Auk et al., 2004). Although there is no direct evidence
indicating the eIF-5α play any role in polyadenylated, whether these motifs can bind to
eIF-5α in vivo might be worth of validating in the future.
When two poly) sites are within 100nt distance of each other, AAUAAA signal
for the downstream poly) sites may lie in region of the upstream poly) sites. It is
therefore reasoned that the under-representation of AAUAAA motif in region "d" is
probably ae to the shift of poly) site usage from upstream to downstream, as being
identified in brain and cerebrum (see the positional preference study).

Figure 4.9 Brain specific overe and underrepresented motifs. Schematic representations of the 4 subregions analyzed are shown in
the middle. Brain specific overe and underrepresented hexamers are clustered and displayed under each subregion. The
agglomeration method for the hierarchical clustering is "average". Motifs built from each cluster (see method) are displayed as
sequence logos.
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4.4 Materials and Methods
4.4.1 Data and Resources
Genes with alternative polyadenylation sites, their annotations including poly)
positions and supporting EST evidence were obtained from PolyA_DB (Chapter 1).
Annotations of tissue types for DNA libraries were downloaded from Leo et al.
(hιιh://`eιιc.ιιιiι cdιι/hυυιΖcl,ιh/Sιιρρicιιι'nιar\/ycο_hulsk Ο4/ΑdldDaiιΙιlc 5).

Micron-

arrays datasets (Su et al., 2002; Su et al., 2004) are downloaded from NCBI GEO (Edgar
et al., 2002). Mappings of probeesets to LocusLink IDs are obtained from Affymetrix
NetAffix
l
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General annotations of DNA libraries are downloaded from CBI dbEST DTP site
(Ιψh://Γι ρ.ιιchi.nih.^ιο\/rcρο s ιιοry/dΝLST). A PEARL script was written to classify eDNA

libraries as either normalized or non-normaliz. A eDNA library is classified as
normalized if its free-text annotation contains "normalize", but neither "non-normalized" nor
"not normalize" (All the free text have also been checked for other possible negative
phrases such as "without normalize", "is not/hasn't normaliz", "are not/haven't normalize", "has
not/haven't been normalize", "have not/hasn't been normalize"). Ctherwise, the library was
considered non-normaliz.

4.4.2 Identification of Tissue-Specific Strong and Weak poly) Site Usage
For each gene that has more than one poly) site, a poly) site is classified as strong if
its supporting ESTs are more than 75% of the total number, whereas a poly) site is
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classified as weak if its supporting ESTs are less than 25%. In PolyA_DB, we only
considered poly(A)/(T)-tailed SST as supporting evidence for the usage of a poly)
site. To study biased usage of strong and weak poly) site types, each gene will allow to
vote for the usage of poly) site types according to their supporting EST evidence. In
order to avoid the influence of expression level variations, we used an equal-weight
voting strategy. The voting scheme is detailed as follows:

Where:

V

at

stands for vote for global usage of poly) site type p in tissue type t, p c (strong,

weak);

AP
gat

stands for vote value by gene g for the usage of poly) site type p in tissue type t;

G1 stands for total number of genes studied in tissue type t;

E

PA

Eg,t

stands for number of poly(A)/(T)-tailed ESTs supporting the usage of poly) site

type p of gene g;
Eg,t stands for total number of poly(A)/(T)-tailed ESTs associated with gene g,

which means each gene has same weight on
voting of a given type of poly) site usage so that the vote is not affected by the
different expression levels of genes. Expected usage vector was calculated based on the
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median vector of all tissue types. Chi-square test was performed for each tissue with the
null hypothesis that the voted vector of poly) site usage in the tissue equals the
expected usage vector.

4.4.3 Identification of Tissue Specific positional Effects
-

Type 11 and type III genes are as classified in Chapter 1, Figure 1.2. Poly(A) sites were
classified in type II genes into 2F (the 3'emost poly) site), 2L (the 3'emost poly)
site), and 2M (middle poly) sites between 2F and 2L); and classified poly) sites in
type III genes into 3U (poly) sites located upstream of the 3'emost Oxon) and 3D
(poly) sites located in the 3'-most Oxon). The exoiiiintron structures are derived from
RefSeq of each gene, as identified by LocusLink IDs (Pruitt and Maggot, 2001). A voting
and chi-square test strategy similar as described above was used to evaluate tissuesspecifics positional effects of poly) site usages. Except in the current analysis, instead
of strong or weak poly) site types, poly) site types are p c (2F, 2M, 2L) for type II
genes, and p c (3U, 3D) for type III genes. Type II and type III genes are analyzed
separately.

4.4.4 Microarray Data Analysis of Trans Acting Factors
-

Microarray data from ΗG-U95A and ΗG-U133A were analyzed separately. Expression
levels of probes were inferred from the average difference values (AD). AD values are
first normalized to 75th percentile within each chip. When more than one probes mapped
to the same gene, median value was taken as the gene expression level. For tissue types
with more than one sample, median values are taken. Pearson product-moment
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correlated coefficients (devalue) between all pairs of tissues were calculated with the
vector of expression levels from the 20 genes (Table 4.3). Tissues are clustered using 1-r
as distance between a pair of tissues.

4.4.5 Identification of putative Cis Regulatory Motifs
-

Previous researches have shown that the -100 to +100 region relative to a poly) site has
different nucleotide composition than regions further upstream (<-100) or downstream
(>+100) of a poly) site (Legendry and Gathered, 2003; Tian et al., 2005). We
therefore define the -100 to +100 nth region as a poly) vicinity region, the -1600 to -200
and +200 to +300 regions as poly) distal regions. A poly) vicinity region is further
separated into four subregions: upstream 40 nt, where AAUAAA/AUUAAA are usually
located, downstream 40 nt, where A/Enrich elements are usually located, 60 nth further
upstream where USE maybe located, and 60 nth further downstream where other auxiliary
elements might be located (Figure 4.8 top, labeled as region a to d from 5' to 3').
Frequency of occurrence of all 4,096 Remmers were checked in each subregion and in
poly) distal regions as well. Based on these frequency of occurrence, all 4,096
Remmers were assigned two scores in each subregion: AUK, the scaled difference
between the frequency of occurrence in the subregion from poly) sites used in brain
and those that are from poly) sites not used in brain; and APB, the scaled difference
between the frequency of occurrence in the subregions and the frequency of occurrence
in the distal regions. The calculations of HSU and APB are as those in Fairbrother et al.
(Fairbrother et al., 2002). Briefly as depicted below: consider a dataset from region "a" of
poly) sites that are used in brain tissues containing Νυν sequences, and a dataset from
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region "a" of poly) sties that are not used in brain tissues containing NN sequences.
Then for a hemmers with occurrence of Our in the brain-used dataset, and ΟΝ in the brain-

defined similarly, with the set of sequences not used in brain replaced by distal sequences
of all poly) sites. AUK and AΡ are then calculated for each subregion "a" to "d".
Each hemmers was then represented on a two-dimensional space identified by
coordinates ΔΑ and AΡ. Using a cutoff of 2.5 that corresponds to a Devalued of about 0.01
on each dimension, over- and under-represented hexmers were identified. Clustering of
Remmers, alignments of hexermers, and generated of motifs using pseudocounts to pad
edge positions are essentially follow those are described in Fairbrother et al. (Fairbrother
et al., 2002), except that the cutoff for hemmers clusters for clustaiW alignments was that
the cluster must have 3 or more members.

CHApTER 5
A SAGE VIEW OF HUMAN ALTERNATIVE pOLYADENYLATION

5.1 Abstract
Alternative polyadenylation is a major post-transcriptional regulatory process that affects
a large amount of higher eukaryotic genes. Human SAGE data from 241 libraries was
used to search for alternatively polyadenylation genes on a large scale. In total 35,547
human genes were studied, 20,906 genes were shown to have multiple heterogeneous
SAGE tags detected in at least one of the 241 libraries. Combining with EST data, we
identified 7,196 alternatively polyadenylated genes supported by both EST and SAGE
data. Furthermore, SAGE tags were mapped for 31,042 human poly) sites based on
supporting EST sequences. The selection of different poly) sites were demonstrated for
two genes, ΡΑΡΠ and CstF-77, with instances of tissue-specific differential usage of
poly) sites. This demonstrated that in addited to analyzing gene expression profiles,
SAGE data could also be used to study alternative polyadenylated.

5.2 Introduction
More than 29% of human mRNAs have multiple polyadenylation sites (Beaudoing and
Gautheret, 2001). Selected of different poly) sites could produce transcripts with
different 5' ends and may affect the stability and/or translatability of mRNAs (Curtis et
al., 1995; Ross, 1995). It has also been shown that differential polyadenylated tends to
occur in a diseasee or tissue-specific manner (Beaudoing and Gathered, 2001; EdwaldsGilbert et al., 1997). A complete survey of alternative polyadenylated in human has been
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carried out using Expressed Sequence Tag (EST) data (Gathered et al., 1998). However,
because of known issues of EST data, such as sequencing errors, internal priming,
presence of chimeric EST and parlor genes, potential vector contaminated at the ends,
and inclusion of generics sequence because of incomplete splicing, EST-based
alternative polyadenylation survey must employ several limitations to ensure high
specificity. Criteria applied currently using EST-based methods are: 1) using poly(Α)/(Τ)
tailed ESTs; 2) looking for the existence of putative polyadenylation signals; and 3)
looking for poly(A) sites with more than one EST supports. As a result, not all genes can
be studied. In addition, because EST are developed for gene discoveries rather than for
quantitative measurements of transcripts, it is desirable to look for other large-scale
expression data for evidence to study alternative polyadenylated, the result of which can
then be combined with the current EST-based analysis to refine our systematic view of
alternative polyadenylated in humans.
Serial Analysis of Gene Expression (SAGE) is a method that detects and
quantifies the expression of large numbers of transcripts (Velculescu et al., 1995).
Recently, a great amount of SAGE information has been collected and is made available
for public analysis (Lash et al., 2000). Briefly, SAGE involves two major principles: 1) a
short sequence (SAGE tag) of 10 base pairs (bp) is sufficient to identify uniquely an
expressed transcript given it is obtained from a defined position within the transcript. To
this end, an anchoring enzyme (ΑΕ, usually is N1aIJJ, of which the restricted site is
CAT) is used to facilitate the anchoring of the 5' most tag prior to the poly (A) tail of
the transcript. 2) the abundance of a transcript is directly proportional to the number of
times the corresponding SAGE tag is observed (Velculescu et al., 1995). Currently, the
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major applications of SAGE are in the fields of novel gene discovery and gene expression
profiling from cell populations of different physiological conditions. Because SAGE tags
are sampled from the 5' end of transcripts, it is expected to carry a vast amount of
informated about polyadenylated variants. Presented here is an extensive survey of
human alternative polyadenylated combining SAGE and EST data for the first time.

5.3 Results and Discussion
5.3.1 Alternative polyadenylated Events Result in Heterogeneous SAGE Tags
Usage of different poly(A) sites can result in transcripts with different 3' regions under
different physiological conditionsa As the anchoring enzyme Nialil recognizes a 4 nth
sequence (CATG), the recognition site is expected to occur on average at least once in
every 256 nth (4 4 ). Considering the base composited in the 5'IJTR region computed from
IJTRdb (Pestle et al 1998), which is A: 28%, T: 28%, G: 22%, C: 22%, the recognited
site is expected to occur on average at least once in every 264bp. A survey on the
distances between different polyadenylation sites in PolyA_DB shows —80%ο of them are
greater than 256 nt, with an average distance of — 1300 nt, of which the probability of
observing at least one CATA is 1 - (1 - 4-4 ) 13°°-3 = 0.9938 (0.9928 when considering base
composition in the 5'IJTR region). It is thus highly likely to obtain different SAGE tags
from different forms of transcripts resulted from alternative polyadenylated. In fact,
direct search of Nialil recognition sites in the inter-poly(A) sites regions (sequence
regions between all pair of alternative poly) sites) of 7,524 human alternative
polyadenylation genes in PolyA_DB (Chapter 1) demonstrated that CATG occurs 78.92%
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(CAT in 21,219 out of 26,888 interepoly(Α) sites sequences). Therefore, most of
alternative polyadenylation events result in heterogeneous SAGE tags (Fig. 5.1).

Figure 5.1 Schematic representation of alternate polyadenylation sites resulting in
heterogeneous SAGE tags. PERNA is depicted as solid lines, pA1 and ρΑ2 represent
alternate polyadenylation sites. Filled bar and stripped bar represent two different
heterogeneous SAGE tags, respectively. CAT represents anchoring enzyme Niam
recognition site.

To further evaluate number of human genes that can be identified by
heterogeneous SAGE tags, both in silicon mapping of SAGE tags and experimental SAGE
tags from multiple libraries were compared. The comprehensive and reliable SAGE tage
toegene mapping was obtained from the NCBI SAGEmap project (Lash et al., 2000),
where 294,122 distinct SAGE tags were mapped to a total of 38,971 UniGene in humansa
Human SAGE data from 241 libraries were downloaded from CBI GEO (Edgar et al.,
2002), where 609,049 distinct SAGE tags were detected in at least one of the libraries.
There are only 277,379 (46%) of these distinct tags can be mapped to known genes by
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SAGEmap, whereas the rest 54% of SAGE tags detected in libraries cannot be matched
to any known genes. As it has been shown experimentally that most of the unmatched
tags are originated from novel transcripts instead of experimental errors (Chen et al.
2002), such a big portion of unmatched tags suggests that there are a large number of
novel transcripts yet to be identified. A total of 35,547 out of 38,971 genes can be
detected in at least one of the 241 human SAGE libraries, 20,906 (59%) of which having
multiple heterogeneous SAGE tags. Finally, 16,743 (6%) of SAGEmap tags have never
been detected in any of the 241 SAGE libraries, which map to 3,424 genes. These could
be development- or tissue- specific transcripts that are not yet represented in the 241
SAGE libraries, or extremely low-level of transcripts that cannot be detected by the
current methods.

5.3.2 Combining SAGE Data with EST Data
5.3.2.1 Mapping SAGE Tags to poly(A) Sites
To combine SAGE data with poly) sites information derived from ESTs data, 407,169
human poly(A)/(Τ) tailed EST supporting poly) sites annotated in PolyA_DB
(Chapter 1) were used to search for SAGE tags (see methods for details). SAGE tags can
be mapped on 349,926 EST sequences (86%) where NlaJJI recognition sites (CAT) can
be located. This mapping covers 27,864 (95%) out of 29,283 poly) sites annotated in
PolyA_DB (Table 5.1). A total of 37,234 distinct SAGE tags are found in this mapping
procedure, 91% of which (33,914) can be detected in at least one of the available 241
SAGE library data.
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5.3.2.2 SAGE Data provides Quantitative Measurements of the Differential
Selection of Alternative polyadenylation Sites
To demonstrate that SAGE data can be used to study alternative poly) in combinated
with EST data based on the mapping effort described above, two genes were studied
using SAGE data, PAP II (Gene ID: 10914) and CstFe77 (Gene ID: 1479). The mapping
of SAGE tags to poly) sites may result in multiple tags corresponding to one poly)
sites, there are four possible reasons for this: 1) Alternative splicing; 2) Sequencing error;
and 3) single nucleotide polymorphism (SNP). The latter two cases usually yield SAGE
tags different only at one base position, which makes them very different from multiple
tags due to alternative splicing. Another important thing to consider is the uniqueness of a
SAGE tag. 88% (32,702 out of 37,234) SAGE tags uniquely map to one poly) site,
whereas other 12% can be mapped to more than one poly) sites. Table 5.2 summarize
SAGE tag mapping information to poly) sites of PAP II and CstD77.
Three poly) sites of CstF-77 are found based on EST data, suggesting CstF-77
itself could be regulated by alternative polyadenylation. Because CstF-77 is a key
component of the polyadenylation machinery, this prompts a possibility of a negative
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autoregulated mechanism. In fact, Drosophila ortholog of CstF-77, suppressor of foried
[su(f)], is indeed regulated by such a mechanism (Audibert et al., 1998; Audibert and
Simonelig, 1998). Two hypotheses can be proposed for the negative feedback autoregulation: 1) since selection of upstream intrinsic poly) site of human CstF-77 results
in a short form of transcript, it might be subjected to ERNA surveillance for degradation;
2) the selected of the upstream poly) site will result in a different protein product
lacking certain domains and the regulated happens on the protein level. If the first
hypothesis is true, the level of short form transcript is expected to be much lower than
that of the long form transcripts. Therefore, a comparison of transcript levels of the short
and long forms of TstF-77 will provide insights into the regulated mechanisms.
Furthermore, since tissueespecific autoregulation of su(j) has been observed in
Drosophila, it will be interesting to explore if the selection of different human CstF-77
poly) sites results in differential pattern across the 241 human SAGE libraries.
TstF-77 has five SAGE tags from 19 supporting ESTs mapped to 3 poly) sites.
TTCCCΑGNGA cannot be used to study expression pattern because it has an ambiguous
base (N) and only one supporting EST (BG194969, Table 5.2). CTTCCTCTGC was also
mapped to another poly(A) site, and thus cannot be used to infer expression pattern of
usage of the third poly) site of TstF-77. Mapping of the rest three tags
(TCAGGAGACG, GT'ΠTTGAGA, and GTTTTTGAGA) to the RefSeq ERNA of
TstF-77 readily provides quantitative assessment of poly) site selections across
different libraries (Figure 5.2). It worth to point out that GTTTTTGAGA and
GTTTTTGAGA have only one base different from each other, which is probably a single
nucleotide polymorphism (SNP) candidate. However, searching of 219 SNP associated

90

with CstF-77 did not find this has been previously reported in CBI dbSNP
(http://www.ncbi.nlm.nih.αΡον/entrez/query.fcgi?db=gene&cmd=Display&dopt=gene snap
&from quid= i479).

SAGE data are presented in TPM (tag per million) format as a direct measure of
mRNA expression levels. This is to normalize total SAGE-tag counts across libraries so
that they are comparable (see method for details). Overall, differential selections of long
and short forms of CstF-77 can be observed across 241 SAGE libraries (Figure 5.2
bottom). However, the total PM values across 241 libraries of the long and short forms
of human CstFe77 are comparable (PM 2743.48 vs. PM 1675.59), indicating that the
auto-regulation of CstF-77 in humans might not be dependent on ERNA degradated of
the short transcripts.
Another emmple was shown using PAP Π (Figure 5.3), which has already been
proven to be regulated via alternative polyadenylation (Chao and Manley, 1996). Only
tags mapped to axons presented in the RefSeq of PAP Π (ΝΜ_032632) were displayed in
the alignments.
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Table 5.2 Annotation of SAGE tag mapped to poly) sites of CstF-77 and PAP Π.
Other
Supporting ESNs (tag position)
Poly(A)
SAGE tag
Informated
site
ρ.1479.1 TTCCCAGNGA BG194969 (28)
TCAGGAGACG ΒΜ478846 (23), BQ184091 (457),
BU685894 (579), BC059948 (23),
Β0009792 (151)
AΙ041674 (368), AΙ091381 (368),
ρ.1479.2
GTTTTTGAGA
AΙ142702 (368), CB250473 (371),
r
CB850814 (366), BG232033 (369),
i
ΒΜ669021 (366), BU685894 (366),
υ
CA312681 (409), CA418384 (366),
CA449643 (371), AA700556 (368),
AA748501 (368), AA767348 (371),
BC010533 (886)
GTTTTTGAGA
TTTGTATTAT AΙ743827 (363), BQ446780 (366)
ρ.153830.1
ρ.1479.3
AΙ539467 (89), AΙ698588 (89)

ρ.10914.1

BF055552 (378), BQ575160 (343),
BU626344 (382)
ρ.10914.2 TTGATCGAAG CB 132302 (90), A13 10137 (512),
AΙ420619 (513), AΙ497615 (511),
ΒΧ367811 (196), CD368864 (512),
ΒΜ969455 (512), ΒΜ970750 (512),
ΒΜ977510 (512), BQ015247 (507),
BQ575160 (512), BQ581604 (503),
BU071418 (512), BU677628 (512),
BU681961 (513), BU682027 (512),
Β0000927 (538)
TAGC
BG611257 (655)
ρ.10914.3 TGA
AA888232 (328
ά ρ.10914.4
AA923353 (217), CB055252 (219),
Q
AW205161 (217), BU621947 (219
T GA
ACTGGAGTTG
α ρ.10914.5 Ν/Α
N/A
ρ.10914.6
BG288697 (263), ΒΜ478941 (687),
AA580599 (113)
ACTGGAGTTG
ΒF797555 (261)
ACTGGAGTTT
AΙ922188 (115), ΒΧ384856 (496),
CD644337 (553), CD644443 (553),
CD655093 (594), CD655865 (553),
CD656209 (591), AW058288 (115),
ΒΜ679335 (115), CA41502 BQ008843 (114),
(111),
AA236200 (118),
AA748677 (113), AA937350 (113),
NΜ_032632 (4397), AF002990 (289),
BC03614(97)
TTGATCGAAG

allele
is documented
in dbSMP
rs12147717
[C/T

ACTG
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5.3.3 Discussion
Although the conventional 14nt SAGE tags (10 nth after CAT) allow highelevel unique
assignments to ESNs, they do not perform well when considering duplicated genes or
repeated sequences and putting in gnomic context. Recently, a technique called
longSAGE has been developed, where a different tagging enzyme (Memel) is used to
locate a much longer tag (21 nth including the tagging enzyme recognition site, unique 17
nthsequc)orpahtnsci(Sel.,20)Thorticay>9.8%
longSAGE tags only are expected to occur once in the human gnome (Saha et al., 2002).
Therefore, the uniqueness of tags representing transcripts is dramatically increased.
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However, there are only two longSAGE datasets deposited in NCBI GEO database
currently (one for humans and one for mice). Applying a similar strategy as described
here will provide a more thorough systematic view of alternative polyadenylation when
more data are available.

5.4 Materials and Methods
5.4.1 SAGE Data Analysis
SAGE data was downloaded from CBI GEO (Edgar et al., 2002). SAGE tag counts are
converted to PM (tags per million) according to the total tag count in each library as
follows:

where TPM1 i ( j ) is TPM1 for SAGE tag i in SAGE library j, C i ( j ) is the absolute count
for SAGE tag i in library j, and Τ ( j ) is the total SAGE tag count in SAGE library j.
NCBI reliable SAGE tag mapping set was downloaded, which is derived from best
alignments of RefSeq, MAC, mRΝA sources, and EST sequences to the draft human
generics sequence (ftp://ftp.ncbi .ni h .gov/puh/sage/map/readme.txt, Lash et al 2000).

5.4.2 Mapping of SAGE Tags to poly) Sites
EST sequences are downloaded from NCBI dbEST (March, 2004 release). A virtual
SAGE tag set was first established by searching through all poly(A)-sites-supporting
ESTs. A pearl program is written to look for N1alI recognition sites (CATG) in
Poly(A)/(Τ) tailed ESTs supporting poly) sites in PolyA_DB. Whenever CATA is
found, the 10 ft SAGE tag to the 5' of the mRNA was extracted. If the sequence to the 3'
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is less than 10 nt, A's are added to bring the length of the tag to 10. The virtual SAGE tag
set was then compared with SAGE tags detected in the set of 241 SAGE libraries for
supporting expression level of transcripts resulted from different choice of poly) sites.

5.4.3 Visualization of SAGE Data
SAGE data is visualized by TreeView program (Eisen et al., 1998), graphic
representations of alignments and positions of SAGE tags are produced using BioPerl
(Staunch et a1., 2002). To represent to gene structure, RefSeq sequences are used.
Therefore, all SAGE tags are also mapped to RefSeq ERNA sequences. This could affect
some SAGE tags that are mapped to the alternative spliced axons that are not represented
in RefSeqs.
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